Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific nTPM	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific nTPM	RNA single nuclei brain specificity	RNA single nuclei brain distribution	RNA single nuclei brain specificity score	RNA single nuclei brain specific nTPM	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific nTPM	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific nTPM	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific nTPM	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific nTPM	RNA tissue cell type enrichment	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific nTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific nTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	Secretome function	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Blood expression cluster	Tissue expression cluster	Brain expression cluster	Cell line expression cluster	Single cell expression cluster	Interactions	Subcellular main location	Subcellular additional location	Antibody RRID	Cancer prognostics - Bladder Urothelial Carcinoma (TCGA)	Cancer prognostics - Breast Invasive Carcinoma (TCGA)	Cancer prognostics - Breast Invasive Carcinoma (validation)	Cancer prognostics - Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA)	Cancer prognostics - Colon Adenocarcinoma (TCGA)	Cancer prognostics - Colon Adenocarcinoma (validation)	Cancer prognostics - Glioblastoma Multiforme (TCGA)	Cancer prognostics - Glioblastoma Multiforme (validation)	Cancer prognostics - Head and Neck Squamous Cell Carcinoma (TCGA)	Cancer prognostics - Kidney Chromophobe (TCGA)	Cancer prognostics - Kidney Renal Clear Cell Carcinoma (TCGA)	Cancer prognostics - Kidney Renal Clear Cell Carcinoma (validation)	Cancer prognostics - Kidney Renal Papillary Cell Carcinoma (TCGA)	Cancer prognostics - Liver Hepatocellular Carcinoma (TCGA)	Cancer prognostics - Liver Hepatocellular Carcinoma (validation)	Cancer prognostics - Lung Adenocarcinoma (TCGA)	Cancer prognostics - Lung Adenocarcinoma (validation)	Cancer prognostics - Lung Squamous Cell Carcinoma (TCGA)	Cancer prognostics - Lung Squamous Cell Carcinoma (validation)	Cancer prognostics - Ovary Serous Cystadenocarcinoma (TCGA)	Cancer prognostics - Ovary Serous Cystadenocarcinoma (validation)	Cancer prognostics - Pancreatic Adenocarcinoma (TCGA)	Cancer prognostics - Pancreatic Adenocarcinoma (validation)	Cancer prognostics - Prostate Adenocarcinoma (TCGA)	Cancer prognostics - Rectum Adenocarcinoma (TCGA)	Cancer prognostics - Rectum Adenocarcinoma (validation)	Cancer prognostics - Skin Cuteneous Melanoma (TCGA)	Cancer prognostics - Stomach Adenocarcinoma (TCGA)	Cancer prognostics - Testicular Germ Cell Tumor (TCGA)	Cancer prognostics - Thyroid Carcinoma (TCGA)	Cancer prognostics - Uterine Corpus Endometrial Carcinoma (TCGA)
A1BG		ENSG00000121410	Alpha-1-B glycoprotein	P04217	19	58345178-58353492	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	1513	liver: 1194.2	Cell type enhanced	Detected in many		"Hepatocytes: 18.2;Oligodendrocytes: 8.1;Plasma cells: 8.2"	Low cell type specificity	Detected in all			Cancer enriched	Detected in single	1025	Liver Hepatocellular Carcinoma (TCGA): 592.9	Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected				Not detected	Not detected			Low region specificity	Detected in many			CAB016673, HPA044252	Supported				Secreted to blood	No annotated function	NA	NA	2E+11	72000000000		Cluster 31: Liver - Plasma proteins	Cluster 17: Choroid plexus - Cilium	Cluster 18: Liver cancer - Metabolism	Cluster 7: T-cells - T-cell receptor	4			CAB016673: AB_1611892, HPA044252: AB_2678876			unprognostic (3.18e-2)											unprognostic (1.96e-3)	unprognostic (3.48e-4)						unprognostic (1.40e-2)		unprognostic (2.30e-1)								
AFM	ALB2, ALBA	ENSG00000079557	Afamin	P43652	4	73481745-73504001	Plasma proteins, Predicted secreted proteins	Protein transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	liver: 932.0	Cell type enriched	Detected in some	8	Hepatocytes: 294.0	Not detected	Not detected			Cancer enriched	Detected in single	94	Liver Hepatocellular Carcinoma (TCGA): 74.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in many			HPA017006, HPA052437	Enhanced		Uncertain	Plasma membrane	Secreted to blood	Transport	NA	NA	54900000000	15000000000		Cluster 1: Liver & Kidney - Metabolism		Cluster 55: Lymphoma - Immune response	Cluster 43: Hepatocytes - Metabolism	2	Plasma membrane		HPA017006: AB_1844635, HPA052437: AB_2732575														unprognostic (4.08e-5)	unprognostic (8.63e-7)																
AFP	FETA, HPAFP	ENSG00000081051	Alpha fetoprotein	P02771	4	73431138-73456174	Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins			Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	10	liver: 3.6	Group enriched	Detected in some	7	"Extravillous trophoblasts: 87.4;Hepatocytes: 131.6;Proximal tubular cells: 124.1"	Cell type enhanced	Detected in single		hippocampal CA4: 1.1	Group enriched	Detected in some	16	"Liver Hepatocellular Carcinoma (TCGA): 199.4;Testicular Germ Cell Tumor (TCGA): 68.4"	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	4	liver cancer: 642.2	Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA010607, HPA023600, CAB024283, CAB025339, CAB080122	Approved		Approved	Golgi apparatus	Secreted to blood	No annotated function	NA	NA	3010000	68000000		Cluster 83: Liver - Metabolism		Cluster 18: Liver cancer - Metabolism	Cluster 56: Proximal tubular cells - Amino acid metabolism	5	Golgi apparatus		CAB024283: AB_2650473, CAB025339: , CAB080122: , HPA010607: AB_1078141, HPA023600: AB_1844769			unprognostic (1.27e-1)											unprognostic (2.00e-1)	unprognostic (4.96e-2)													unprognostic (1.04e-2)	unprognostic (6.89e-2)		
AGT	SERPINA8	ENSG00000135744	Angiotensinogen	P01019	1	230690776-230745576	Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins		Vasoactive, Vasoconstrictor	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	liver: 1563.6	Group enriched	Detected in many	4	"Cholangiocytes: 984.4;Hepatocytes: 1899.1"	Group enriched	Detected in many	4	"astrocyte: 277.4;ependymal cell: 438.0"	Group enriched	Detected in all	9	"Glioblastoma Multiforme (TCGA): 391.4;Liver Hepatocellular Carcinoma (TCGA): 1349.9"	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	6	liver cancer: 204.0	Kidney - Proximal tubular cells, Liver - Hepatocytes, Testis - Late spermatids	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB025798	Supported				Secreted to blood	Other	NA	NA	5940000	48000000000		Cluster 83: Liver - Metabolism	Cluster 44: Non-specific - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	13			CAB025798: 	unprognostic (2.28e-1)	unprognostic (2.39e-1)	unprognostic (1.97e-1)	unprognostic (1.96e-1)	unprognostic (2.65e-2)	unprognostic (8.58e-3)	unprognostic (1.99e-1)	unprognostic (1.71e-1)	unprognostic (3.26e-2)	unprognostic (6.64e-2)	unprognostic (6.83e-4)	unprognostic (8.93e-3)	unprognostic (1.97e-1)	unprognostic (2.27e-2)	unprognostic (1.78e-2)	unprognostic (2.29e-1)	unprognostic (6.35e-2)	unprognostic (1.39e-2)	unprognostic (1.07e-2)	unprognostic (2.69e-2)		unprognostic (7.66e-3)	unprognostic (6.17e-2)	unprognostic (1.58e-1)	unprognostic (2.44e-1)	unprognostic (8.16e-2)	unprognostic (5.92e-2)	unprognostic (4.81e-3)	unprognostic (1.05e-1)	unprognostic (7.15e-2)	unprognostic (3.64e-2)
AHSG	A2HS, FETUA, HSGA	ENSG00000145192	Alpha 2-HS glycoprotein	P02765	3	186613060-186621318	Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins	Mineral balance		Cancer-related genes, Disease variant, Hypotrichosis, Intellectual disability	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4328	liver: 5638.7	Cell type enriched	Detected in some	14	Hepatocytes: 1120.0	Cell type enhanced	Detected in some		deep-layer corticothalamic and 6b: 1.6	Cancer enriched	Detected in some	234	Liver Hepatocellular Carcinoma (TCGA): 2018.7	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	18	liver cancer: 479.5	Liver - Hepatocytes, Testis - Late spermatids	Not detected	Not detected			Not detected	Not detected			HPA001524, HPA001525, CAB026209	Enhanced		Enhanced	Golgi apparatus	Secreted to blood	Other	NA	NA	8,64E+11	1,1E+11		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	8	Golgi apparatus		CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849											unprognostic (5.38e-3)			unprognostic (3.71e-2)	unprognostic (3.67e-2)			unprognostic (1.16e-1)										unprognostic (2.76e-2)	unprognostic (5.63e-2)		
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421482	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins			Cancer-related genes, Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	136	liver: 205952.1	Cell type enriched	Detected in many	4	Hepatocytes: 59612.0	Low cell type specificity	Detected in many			Cancer enriched	Detected in many	422	Liver Hepatocellular Carcinoma (TCGA): 32792.0	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	24	liver cancer: 1846.4	Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			CAB006262, HPA031024, HPA031025	Enhanced		Approved	Endoplasmic reticulum,Golgi apparatus	Secreted to blood	Transport	NA	NA	4E+13			Cluster 31: Liver - Plasma proteins	Cluster 33: Neurons - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	24	Endoplasmic reticulum, Golgi apparatus		CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704	unprognostic (6.95e-3)	unprognostic (2.75e-1)	unprognostic (7.30e-2)	unprognostic (6.46e-2)							unprognostic (2.52e-4)	unprognostic (3.74e-4)	unprognostic (2.18e-1)	unprognostic (1.74e-2)	unprognostic (3.65e-3)	unprognostic (1.17e-2)	unprognostic (7.29e-2)	unprognostic (2.57e-1)	unprognostic (3.58e-1)			unprognostic (4.51e-2)	unprognostic (4.52e-4)	unprognostic (3.56e-2)	unprognostic (2.35e-1)		unprognostic (3.31e-1)	unprognostic (1.95e-3)	unprognostic (5.35e-2)		unprognostic (2.61e-1)
AMBP	EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI	ENSG00000106927	Alpha-1-microglobulin/bikunin precursor	P02760	9	114060127-114078328	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Host-virus interaction	Oxidoreductase, Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	68	liver: 10607.0	Group enriched	Detected in many	23	"Cholangiocytes: 2459.2;Hepatocytes: 9092.4"	Cell type enriched	Detected in some	7	ependymal cell: 10.4	Cancer enriched	Detected in many	111	Liver Hepatocellular Carcinoma (TCGA): 4655.8	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	8	liver cancer: 556.5	Breast - Breast glandular cells, Liver - Hepatocytes, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in all			HPA001497, CAB069436, HPA075585	Approved		Approved	Golgi apparatus,Vesicles,Cytosol	Secreted to blood	Enzyme	NA	NA	3300000000	40000000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	4	Vesicles	Golgi apparatus, Cytosol	CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: 		unprognostic (8.76e-2)	unprognostic (8.75e-3)		unprognostic (4.05e-2)						unprognostic (2.81e-3)	unprognostic (2.05e-1)	unprognostic (1.38e-3)	unprognostic (1.52e-2)	unprognostic (8.18e-3)	unprognostic (1.53e-2)	unprognostic (2.91e-1)	unprognostic (2.68e-2)		unprognostic (1.15e-2)		unprognostic (1.81e-1)	unprognostic (1.01e-2)		unprognostic (2.78e-1)		unprognostic (4.70e-1)	unprognostic (1.25e-3)	unprognostic (5.63e-2)		unprognostic (4.58e-1)
ANG	RAA1, RNASE5	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins	Angiogenesis, Differentiation, Stress response	Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor	Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	52	liver: 2920.4	Cell type enriched	Detected in many	25	Hepatocytes: 5169.3	Not detected	Not detected			Cancer enriched	Detected in all	16	Liver Hepatocellular Carcinoma (TCGA): 708.5	Low region specificity	Detected in all			Immune cell enhanced	Detected in many		"classical monocyte: 24.6;myeloid DC: 14.6"	Low lineage specificity	Detected in many			Low cancer specificity	Detected in all			Heart muscle - Fibroblasts, Liver - Hepatocytes, Liver - Hepatocytes, Minor Salivary Gland - Minor salivary glandular cells, Stomach - Gastric mucous cells, Testis - Sertoli cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA055896			Approved	Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments	Secreted to blood	Developmental protein	Yes	No	308000000	260000000	Cluster 2: Dendritic cells - Unknown function	Cluster 31: Liver - Plasma proteins	Cluster 39: Astrocytes - Mixed function	Cluster 2: Mucus-secreting cells - Unknown function	Cluster 43: Hepatocytes - Metabolism	8	Nucleoli, Nucleoli rim, Mitotic chromosome	Actin filaments	HPA055896: 	unprognostic (1.12e-1)	unprognostic (3.02e-1)	unprognostic (6.76e-2)	unprognostic (3.64e-2)	unprognostic (1.24e-1)	unprognostic (2.14e-1)	unprognostic (5.81e-4)	unprognostic (1.28e-2)	unprognostic (6.31e-2)	unprognostic (5.09e-2)	unprognostic (1.05e-5)	unprognostic (2.99e-6)	unprognostic (3.77e-2)	unprognostic (3.26e-5)	unprognostic (4.31e-4)	unprognostic (5.92e-2)	unprognostic (1.66e-1)	unprognostic (5.14e-2)	unprognostic (6.93e-2)	unprognostic (7.36e-2)	unprognostic (3.30e-1)	unprognostic (3.06e-1)	unprognostic (1.79e-3)	unprognostic (3.00e-1)	unprognostic (2.61e-1)	unprognostic (4.18e-6)	unprognostic (2.11e-2)	unprognostic (1.19e-2)	unprognostic (1.09e-1)	unprognostic (7.09e-2)	unprognostic (8.92e-2)
ANGPTL3	ANGPT5	ENSG00000132855	Angiopoietin like 3	Q9Y5C1	1	62597520-62606313	Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins	Angiogenesis, Cell adhesion, Lipid metabolism	Heparin-binding	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	liver: 655.3	Group enriched	Detected in some	22	"Hepatocytes: 694.2;Proximal tubular cells: 210.2"	Cell type enhanced	Detected in single		astrocyte: 1.4	Cancer enriched	Detected in some	25	Liver Hepatocellular Carcinoma (TCGA): 106.8	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	39	liver cancer: 9.2	Kidney - Proximal tubular cells, Liver - Hepatocytes, Liver - Hepatocytes, Stomach - Parietal cells	Not detected	Not detected			Low region specificity	Detected in all			HPA038097	Approved				Secreted to blood	Cell adhesion	NA	NA	225000000	88000000		Cluster 1: Liver & Kidney - Metabolism	Cluster 31: Non-specific - Transcription	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism				HPA038097: AB_10675628			unprognostic (2.65e-1)								unprognostic (1.09e-5)	unprognostic (2.43e-5)	unprognostic (2.44e-2)	unprognostic (6.31e-2)	unprognostic (3.98e-4)																
ANGPTL6	AGF, ARP5	ENSG00000130812	Angiopoietin like 6	Q8NI99	19	10092338-10102678	Plasma proteins, Predicted secreted proteins	Angiogenesis, Differentiation	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	liver: 29.4	Cell type enriched	Detected in some	10	Granulosa cells: 109.3	Cell type enhanced	Detected in many		central nervous system macrophage: 6.1	Group enriched	Detected in some	5	"Glioblastoma Multiforme (TCGA): 1.6;Liver Hepatocellular Carcinoma (TCGA): 2.1;Prostate Adenocarcinoma (TCGA): 3.2;Testicular Germ Cell Tumor (TCGA): 3.7;Uterine Corpus Endometrial Carcinoma (TCGA): 4.7"	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	"Leukemia: 13.2;lymphoma: 6.5"	Liver - Hepatic stellate cells, Spleen - B-cells (Spleen), Thyroid gland - T-cells	Low region specificity	Detected in all			Low region specificity	Detected in many								Secreted to blood	Developmental protein	NA	NA	450000	44000000	Cluster 16: Non-specific - Cell proliferation	Cluster 83: Liver - Metabolism	Cluster 20: Macrophages & Microglia - Immune response	Cluster 47: Leukemia - Hemostasis	Cluster 15: Non-specific - Mixed function							unprognostic (1.09e-2)				unprognostic (2.79e-1)							unprognostic (4.69e-2)	unprognostic (2.74e-3)									unprognostic (2.68e-1)					unprognostic (5.05e-2)		unprognostic (2.20e-2)
ANGPTL8	C19orf80, RIFL, TD26	ENSG00000130173	Angiopoietin like 8	Q6UXH0	19	11237450-11241943	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Lipid metabolism	Hormone	Diabetes mellitus	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	12	liver: 399.9	Cell type enriched	Detected in some	11	Hepatocytes: 124.8	Cell type enhanced	Detected in some		pericyte: 1.5	Cancer enriched	Detected in some	26	Liver Hepatocellular Carcinoma (TCGA): 155.2	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	11	liver cancer: 9.6	Minor Salivary Gland - Adipocytes (Minor salivary gland)	Not detected	Not detected			Not detected	Not detected			HPA042131			Approved	Nucleoplasm,Golgi apparatus	Secreted to blood	Hormone	NA	NA	836000	770000		Cluster 83: Liver - Metabolism	Cluster 47: Endothelial cells - Vasculature	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	1	Golgi apparatus	Nucleoplasm	HPA042131: AB_10794413						unprognostic (5.98e-2)					unprognostic (1.23e-5)	unprognostic (4.80e-2)	unprognostic (2.35e-1)	unprognostic (2.64e-1)												unprognostic (6.89e-2)					
APCS	MGC88159, PTX2, SAP	ENSG00000132703	Amyloid P component, serum	P02743	1	159587826-159588865	Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	76	liver: 3515.6	Cell type enriched	Detected in some	10	Hepatocytes: 4133.8	Not detected	Not detected			Cancer enriched	Detected in some	22	Liver Hepatocellular Carcinoma (TCGA): 978.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	10	liver cancer: 14.2	Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			CAB007817, HPA053294	Supported				Secreted to blood	No annotated function	NA	NA	27700000000	23000000000		Cluster 31: Liver - Plasma proteins		Cluster 7: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	9			CAB007817: AB_598185, HPA053294: AB_2682104											unprognostic (7.73e-2)	unprognostic (1.21e-1)	unprognostic (1.75e-2)	unprognostic (1.38e-2)	unprognostic (2.45e-5)							unprognostic (2.42e-2)	unprognostic (1.65e-5)								
APOA1		ENSG00000118137	Apolipoprotein A1	P02647	11	116835751-116837622	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport		Amyloidosis, Atherosclerosis, Cancer-related genes, Disease variant, Neuropathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	liver: 18779.1	Group enriched	Detected in many	13	"Hepatocytes: 24174.5;Proximal enterocytes: 12804.9"	Low cell type specificity	Detected in many			Cancer enriched	Detected in many	46	Liver Hepatocellular Carcinoma (TCGA): 8336.4	Low region specificity	Detected in some			Immune cell enhanced	Detected in single		plasmacytoid DC: 1.2	Low lineage specificity	Detected in single			Group enriched	Detected in some	14	"Gastric cancer: 176.6;liver cancer: 494.9"	Liver - Hepatocytes, Testis - Sertoli cells	Not detected	Not detected			Low region specificity	Detected in all			CAB016778, HPA046715	Supported		Approved	Vesicles,Cytosol	Secreted to blood	Apolipoprotein	NA	NA	1,45E+12	1,3E+11		Cluster 83: Liver - Metabolism	Cluster 34: Non-specific - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	47	Vesicles	Cytosol	CAB016778: , HPA046715: AB_2679768			unprognostic (1.71e-1)	unprognostic (2.89e-3)							unprognostic (2.16e-3)			unprognostic (1.77e-3)	unprognostic (1.23e-2)	unprognostic (4.42e-2)		unprognostic (1.27e-1)		unprognostic (2.66e-2)	unprognostic (4.26e-3)	unprognostic (7.48e-4)	unprognostic (8.56e-2)		unprognostic (1.58e-2)		unprognostic (1.66e-1)	unprognostic (8.08e-3)	unprognostic (1.30e-1)	unprognostic (2.31e-2)	unprognostic (3.68e-2)
APOA2		ENSG00000158874	Apolipoprotein A2	P02652	1	161222292-161223631	Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters	Host-virus interaction, Lipid transport, Transport		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	1343	liver: 34742.6	Cell type enriched	Detected in some	78	Hepatocytes: 51864.9	Cell type enriched	Detected in single	4	hippocampal dentate gyrus: 1.3	Cancer enriched	Detected in many	325	Liver Hepatocellular Carcinoma (TCGA): 33746.8	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	9	liver cancer: 2178.7	Liver - Hepatocytes	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB025885, HPA072575	Supported				Secreted to blood	Apolipoprotein	NA	NA	1,15E+11	60000000000	Cluster 37: Monocytes & Neutrophils - Innate immune response	Cluster 31: Liver - Plasma proteins	Cluster 12: Non-specific - Vasculature	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	27			CAB025885: , HPA072575: 	unprognostic (1.47e-1)			unprognostic (6.59e-2)	unprognostic (4.00e-1)	unprognostic (4.40e-2)					unprognostic (9.14e-2)		unprognostic (8.54e-2)	unprognostic (1.26e-1)	unprognostic (2.29e-2)	unprognostic (2.36e-1)		unprognostic (1.70e-1)				unprognostic (1.72e-2)	unprognostic (1.34e-1)		unprognostic (1.82e-1)	unprognostic (1.04e-1)	unprognostic (1.19e-1)	unprognostic (4.41e-3)	unprognostic (2.47e-1)		unprognostic (6.03e-1)
APOA5	APOA-V, RAP3	ENSG00000110243	Apolipoprotein A5	Q6Q788	11	116789367-116792420	Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins	Lipid transport, Transport		Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	218	liver: 567.7	Cell type enriched	Detected in some	59	Hepatocytes: 1096.0	Not detected	Not detected			Cancer enriched	Detected in single	295	Liver Hepatocellular Carcinoma (TCGA): 144.8	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	18	liver cancer: 2.7	Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Not detected	Not detected								Secreted to blood	Apolipoprotein	NA	NA	114000000	15000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	12						unprognostic (2.77e-1)											unprognostic (7.77e-3)	unprognostic (6.47e-4)																
APOC1		ENSG00000130208	Apolipoprotein C1	P02654	19	44914247-44919349	Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins	Lipid transport, Transport		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	9	liver: 17322.1	Cell type enriched	Detected in many	8	Hepatocytes: 34314.8	Group enriched	Detected in many	6	"astrocyte: 54.1;central nervous system macrophage: 105.4"	Cancer enriched	Detected in all	15	Liver Hepatocellular Carcinoma (TCGA): 11590.2	Low region specificity	Detected in all			Immune cell enriched	Detected in single	8	myeloid DC: 5.9	Lineage enriched	Detected in single	14	dendritic cells: 5.9	Cancer enhanced	Detected in all		"Leukemia: 273.6;liver cancer: 289.3"	Liver - Hepatocytes, Lung - Macrophages, Minor Salivary Gland - Macrophages, Skin - Sebaceous gland cells, Spleen - Macrophages	Low region specificity	Detected in all							HPA051518	Supported				Secreted to blood	Apolipoprotein	NA	NA	20300000000	11000000000	Cluster 2: Dendritic cells - Unknown function	Cluster 83: Liver - Metabolism	Cluster 21: Non-specific - Metabolism	Cluster 47: Leukemia - Hemostasis	Cluster 43: Hepatocytes - Metabolism	25			HPA051518: AB_2681519	unprognostic (3.17e-1)	unprognostic (8.96e-2)	unprognostic (2.62e-1)	unprognostic (4.53e-3)	unprognostic (1.92e-2)	unprognostic (5.38e-2)	unprognostic (2.68e-1)	unprognostic (1.24e-1)	unprognostic (2.48e-1)	unprognostic (2.21e-2)	unprognostic (7.14e-3)	unprognostic (1.68e-2)	unprognostic (1.65e-2)	unprognostic (1.01e-7)	unprognostic (2.49e-5)	unprognostic (3.84e-2)	unprognostic (1.94e-3)	unprognostic (1.02e-1)	unprognostic (7.58e-2)	unprognostic (1.79e-1)	unprognostic (5.84e-2)	unprognostic (2.04e-2)	unprognostic (2.55e-1)	unprognostic (1.90e-1)	unprognostic (5.92e-3)	unprognostic (7.11e-2)	unprognostic (1.70e-1)	unprognostic (2.70e-3)	unprognostic (8.41e-2)	unprognostic (2.97e-3)	unprognostic (1.75e-1)
APOC2		ENSG00000234906	Apolipoprotein C2	P02655	19	44946035-44949565	Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins	Lipid degradation, Lipid metabolism, Lipid transport, Transport		Disease variant, Hyperlipidemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	130	liver: 9320.5	Cell type enriched	Detected in some	23	Hepatocytes: 820.6	Cell type enriched	Detected in some	47	central nervous system macrophage: 326.4	Cancer enriched	Detected in all	22	Liver Hepatocellular Carcinoma (TCGA): 5671.6	Low region specificity	Detected in all			Immune cell enriched	Detected in single	29	NK-cell: 3.2	Lineage enriched	Detected in single	29	NK-cells: 3.2	Cancer enhanced	Detected in many		"Brain cancer: 55.3;Leukemia: 80.3;liver cancer: 81.2"	Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Pancreas - Macrophages	Not detected	Not detected			Not detected	Not detected			HPA055877	Supported				Secreted to blood	Apolipoprotein	NA	NA	43000000000	27000000000	Cluster 14: Non-specific - Unknown function	Cluster 31: Liver - Plasma proteins	Cluster 20: Macrophages & Microglia - Immune response	Cluster 70: DU4475 - Unknown function	Cluster 62: Hepatocytes - Metabolism	3			HPA055877: AB_2682953	unprognostic (1.18e-1)	unprognostic (1.89e-1)	unprognostic (5.55e-2)	unprognostic (5.73e-2)	unprognostic (8.69e-2)	unprognostic (2.19e-2)	unprognostic (6.92e-2)	unprognostic (4.55e-1)	unprognostic (1.35e-1)	unprognostic (1.00e-1)	unprognostic (2.04e-4)	unprognostic (2.54e-2)	unprognostic (1.46e-1)	unprognostic (1.28e-2)	unprognostic (2.32e-3)	unprognostic (4.92e-2)	unprognostic (1.13e-1)	unprognostic (2.34e-1)	unprognostic (5.16e-1)	unprognostic (1.84e-1)		unprognostic (1.96e-1)		unprognostic (4.16e-1)	unprognostic (3.70e-2)	unprognostic (3.43e-2)	unprognostic (6.90e-2)	unprognostic (9.68e-2)	unprognostic (1.05e-1)	unprognostic (2.60e-2)	unprognostic (2.31e-2)
APOC3	Apo-C3, Apo-CIII, ApoC-3, ApoC-III, APOCIII	ENSG00000110245	Apolipoprotein C3	P02656	11	116829706-116833072	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins	Lipid degradation, Lipid metabolism, Lipid transport, Transport		Cancer-related genes, Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	25	liver: 26980.2	Cell type enriched	Detected in some	9	Hepatocytes: 87587.5	Not detected	Not detected			Cancer enriched	Detected in many	432	Liver Hepatocellular Carcinoma (TCGA): 10110.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	4	liver cancer: 40.4	Kidney - Proximal tubular cells, Liver - Hepatocytes	Low region specificity	Detected in some			Not detected	Not detected			HPA065365, HPA073918	Supported		Approved	Nucleoplasm,Nucleoli,Cell Junctions	Secreted to blood	Apolipoprotein	NA	NA	1,06E+11	27000000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	8	Nucleoplasm	Nucleoli, Cell Junctions	HPA065365: AB_2732733, HPA073918: 			unprognostic (7.06e-1)								unprognostic (7.76e-2)	unprognostic (2.55e-3)	unprognostic (3.62e-1)	unprognostic (3.08e-4)	unprognostic (3.59e-4)							unprognostic (1.55e-1)	unprognostic (1.48e-1)		unprognostic (4.96e-1)			unprognostic (2.96e-3)	unprognostic (4.05e-2)		
APOC4		ENSG00000267467	Apolipoprotein C4	P55056	19	44942237-44945496	Plasma proteins, Predicted secreted proteins	Lipid transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	505	liver: 607.5	Cell type enriched	Detected in single	40	Hepatocytes: 15.2	Cell type enhanced	Detected in some		"astrocyte: 1.3;central nervous system macrophage: 3.8"	Cancer enriched	Detected in some	121	Liver Hepatocellular Carcinoma (TCGA): 406.8	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA062671	Approved				Secreted to blood	Apolipoprotein	NA	NA	1000000000	810000000	Cluster 38: Monocytes & Neutrophils - Degranulation	Cluster 31: Liver - Plasma proteins	Cluster 34: Non-specific - Mixed function	Cluster 47: Leukemia - Hemostasis	Cluster 43: Hepatocytes - Metabolism	22			HPA062671: AB_2684828			unprognostic (1.19e-3)											unprognostic (7.36e-4)	unprognostic (2.57e-5)																unprognostic (1.41e-1)
APOF		ENSG00000175336	Apolipoprotein F	Q13790	12	56360568-56362857	Plasma proteins, Predicted secreted proteins	Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	346	liver: 404.0	Cell type enriched	Detected in some	5	Hepatocytes: 299.3	Not detected	Not detected			Cancer enriched	Detected in some	6	Liver Hepatocellular Carcinoma (TCGA): 36.4	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		prostate cancer: 1.0	Liver - Hepatocytes, Minor Salivary Gland - Minor salivary glandular cells, Prostate - Prostate glandular cells, Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected												Secreted to blood	Apolipoprotein	NA	NA	18000000000	1300000000		Cluster 31: Liver - Plasma proteins	Cluster 48: Non-specific - Mixed function	Cluster 16: Thyroid cancer - Neuronal signaling	Cluster 62: Hepatocytes - Metabolism	2						unprognostic (1.17e-1)											unprognostic (4.29e-3)	unprognostic (1.23e-3)									unprognostic (1.41e-1)							
APOH	B2G1, BG	ENSG00000091583	Apolipoprotein H	P02749	17	66212033-66256525	Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Heparin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	567	liver: 17409.3	Cell type enriched	Detected in some	29	Hepatocytes: 7848.6	Not detected	Not detected			Cancer enriched	Detected in many	213	Liver Hepatocellular Carcinoma (TCGA): 3763.9	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	46	liver cancer: 154.3	Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Alveolar cells type 2, Pancreas - Alpha cells	Low region specificity	Detected in many			Not detected	Not detected			HPA001654, HPA003732, CAB022214	Enhanced		Supported	Golgi apparatus	Secreted to blood	Apolipoprotein	NA	NA	2,47E+11	54000000000		Cluster 31: Liver - Plasma proteins	Cluster 53: Neurons - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	9	Golgi apparatus		CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183						unprognostic (2.16e-2)					unprognostic (1.19e-3)	unprognostic (2.24e-3)	unprognostic (5.05e-2)	unprognostic (1.28e-7)	unprognostic (4.60e-3)	unprognostic (9.89e-2)	unprognostic (1.18e-1)					unprognostic (5.62e-3)	unprognostic (1.43e-2)	unprognostic (2.31e-2)	unprognostic (1.17e-1)	unprognostic (2.49e-1)	unprognostic (1.06e-2)	unprognostic (7.57e-3)			unprognostic (1.20e-1)
APOM	Apo-M, G3a, NG20	ENSG00000204444	Apolipoprotein M	O95445	6	31652416-31658210	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Lipid transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	liver: 381.2	Group enriched	Detected in many	7	"Hepatocytes: 703.0;Proximal tubular cells: 402.9"	Low cell type specificity	Detected in some			Cancer enriched	Detected in some	9	Liver Hepatocellular Carcinoma (TCGA): 70.4	Low region specificity	Detected in single			Immune cell enhanced	Detected in some		basophil: 3.0	Low lineage specificity	Detected in many			Cancer enhanced	Detected in some		liver cancer: 6.4	Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in all			CAB034086, HPA051006	Approved		Approved	Golgi apparatus	Secreted to blood	Apolipoprotein	NA	NA	7400000000	5000000000	Cluster 32: Basophils - Transcription	Cluster 1: Liver & Kidney - Metabolism	Cluster 25: Non-specific - Transcription	Cluster 18: Liver cancer - Metabolism	Cluster 56: Proximal tubular cells - Amino acid metabolism	14	Golgi apparatus		CAB034086: AB_1119033, HPA051006: AB_2681307			unprognostic (1.31e-1)				unprognostic (1.76e-1)	unprognostic (1.07e-1)			unprognostic (5.08e-6)	unprognostic (4.39e-6)	unprognostic (6.89e-2)	unprognostic (4.41e-1)	unprognostic (4.40e-3)						unprognostic (2.17e-1)		unprognostic (6.72e-2)						unprognostic (3.81e-1)		
ASGR1	CLEC4H1	ENSG00000141505	Asialoglycoprotein receptor 1	P07306	17	7173431-7179564	Predicted intracellular proteins, Predicted secreted proteins	Endocytosis, Host-virus interaction	Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	41	liver: 1065.6	Cell type enriched	Detected in many	4	Hepatocytes: 976.9	Cell type enhanced	Detected in many		cerebellar inhibitory: 37.7	Cancer enriched	Detected in all	61	Liver Hepatocellular Carcinoma (TCGA): 419.8	Low region specificity	Detected in all			Group enriched	Detected in many	5	"classical monocyte: 115.4;intermediate monocyte: 55.6;myeloid DC: 41.2"	Group enriched	Detected in many	8	"dendritic cells: 41.2;monocytes: 115.4"	Cancer enriched	Detected in many	11	liver cancer: 80.4	Testis - Early spermatids, Testis - Late spermatids	Region enriched	Detected in all	9	cerebellum: 44.1	Not detected	Not detected			HPA011954, HPA012852	Enhanced		Supported	Vesicles,Cell Junctions	Secreted to blood	Receptor	NA	NA	1710000	110000	Cluster 26: Monocytes - Plasma membrane proteins	Cluster 31: Liver - Plasma proteins	Cluster 2: Neurons - Nucleosome	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	31	Vesicles	Cell Junctions	HPA011954: AB_1845079, HPA012852: AB_1845080	unprognostic (1.02e-1)	unprognostic (4.73e-3)	unprognostic (3.01e-1)	unprognostic (1.52e-1)	unprognostic (2.05e-1)	unprognostic (4.73e-2)	unprognostic (6.00e-2)		unprognostic (3.63e-2)	unprognostic (1.52e-2)	unprognostic (6.16e-11)	unprognostic (5.14e-2)	unprognostic (2.09e-2)	unprognostic (6.61e-3)	unprognostic (9.46e-4)	unprognostic (8.94e-3)	unprognostic (1.82e-1)	unprognostic (7.29e-2)	unprognostic (3.19e-2)	unprognostic (1.50e-1)	unprognostic (9.38e-2)	unprognostic (4.70e-3)		unprognostic (1.53e-1)	unprognostic (1.74e-1)	unprognostic (1.34e-1)	unprognostic (8.28e-3)	unprognostic (2.08e-1)	unprognostic (8.05e-2)	unprognostic (4.43e-4)	unprognostic (4.19e-2)
BCHE	CHE1, CHE2, E1	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837462	Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Hydrolase, Serine esterase	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	13	liver: 508.2	Group enriched	Detected in many	7	"Hepatocytes: 505.6;Mesothelial cells: 169.6;Oligodendrocyte precursor cells: 197.2"	Cell type enhanced	Detected in many		"committed oligodendrocyte precursor: 92.9;oligodendrocyte precursor cell: 269.3"	Group enriched	Detected in many	5	"Glioblastoma Multiforme (TCGA): 59.0;Kidney Renal Papillary Cell Carcinoma (TCGA): 15.3;Liver Hepatocellular Carcinoma (TCGA): 35.2;Skin Cuteneous Melanoma (TCGA): 33.0"	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Adipose visceral - Mesothelial cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Minor Salivary Gland - Fibroblasts, Pituitary gland - Corticotropes, Prostate - Smooth muscle cells, Testis - Early spermatids	Low region specificity	Detected in all							HPA001560	Approved				Secreted to blood	Enzyme	NA	NA	3820000000	5500000000		Cluster 83: Liver - Metabolism	Cluster 13: Oligodendrocytes - Mixed function	Cluster 51: Myeloma - Immunoglobulins	Cluster 43: Hepatocytes - Metabolism	8			HPA001560: AB_1078271	unprognostic (1.09e-1)	unprognostic (9.17e-2)	unprognostic (3.03e-2)				unprognostic (3.77e-2)	unprognostic (1.90e-1)	unprognostic (7.60e-5)		unprognostic (6.00e-2)	unprognostic (1.70e-3)	unprognostic (3.54e-1)	unprognostic (1.46e-1)	unprognostic (4.73e-3)	unprognostic (1.26e-1)	unprognostic (5.23e-2)	unprognostic (1.30e-1)	unprognostic (1.65e-1)	unprognostic (8.93e-2)		unprognostic (4.44e-2)	unprognostic (3.94e-1)	unprognostic (1.06e-1)		unprognostic (7.71e-2)	unprognostic (2.72e-2)	unprognostic (1.60e-3)	unprognostic (1.01e-2)	unprognostic (5.93e-2)	unprognostic (1.65e-2)
C1S		ENSG00000182326	Complement C1s	P09871	12	6988259-7071032	Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Complement pathway, Immunity, Innate immunity	Hydrolase, Protease, Serine protease	Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	5	liver: 2762.6	Cell type enhanced	Detected in many		"Fibroblasts: 717.8;Hepatocytes: 2248.0;Leydig cells: 1204.3;Mesothelial cells: 578.3;Ovarian stromal cells: 401.7;Peritubular cells: 631.2"	Cell type enriched	Detected in all	5	fibroblast: 348.0	Cancer enhanced	Detected in all		Liver Hepatocellular Carcinoma (TCGA): 638.4	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Breast - Fibroblasts, Liver - Hepatocytes, Lung - Fibroblast_2, Skin - Fibroblast_2, Spleen - Fibroblast_2	Low region specificity	Detected in many			Low region specificity	Detected in all			CAB016722, HPA018852	Supported		Approved	Nucleoplasm,Cytosol	Secreted to blood	Complement pathway	NA	NA	93000000000	20000000000		Cluster 31: Liver - Plasma proteins	Cluster 39: Astrocytes - Mixed function	Cluster 44: Connective tissue cells - ECM organization	Cluster 53: Fibroblasts - ECM organization	3	Nucleoplasm	Cytosol	CAB016722: , HPA018852: AB_1847112	unprognostic (7.81e-3)	unprognostic (3.39e-3)	unprognostic (1.77e-1)	unprognostic (9.25e-2)	unprognostic (5.15e-2)	unprognostic (5.22e-2)	unprognostic (1.59e-2)	unprognostic (2.59e-3)	unprognostic (2.10e-1)	unprognostic (5.14e-2)	unprognostic (2.07e-5)	unprognostic (3.67e-3)	unprognostic (1.79e-4)	unprognostic (4.98e-4)	unprognostic (1.78e-5)	unprognostic (1.19e-1)	unprognostic (7.56e-2)	unprognostic (8.51e-2)	unprognostic (5.58e-3)	unprognostic (1.12e-2)	unprognostic (1.11e-1)	unprognostic (1.48e-1)	unprognostic (1.05e-2)	unprognostic (4.62e-2)	unprognostic (6.79e-2)	unprognostic (4.51e-3)	unprognostic (3.24e-1)	unprognostic (5.38e-2)	unprognostic (1.94e-3)	unprognostic (1.27e-2)	unprognostic (1.06e-3)
C2		ENSG00000166278	Complement C2	P06681	6	31897785-31945673	Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins	Complement pathway, Immunity, Innate immunity	Hydrolase, Protease, Serine protease	Age-related macular degeneration, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	liver: 466.0	Cell type enhanced	Detected in many		"Alveolar cells type 2: 194.1;Hepatocytes: 323.8;Hofbauer cells: 241.9;Kupffer cells: 141.5"	Low cell type specificity	Detected in all			Cancer enriched	Detected in all	4	Liver Hepatocellular Carcinoma (TCGA): 214.5	Low region specificity	Detected in all			Immune cell enhanced	Detected in some		"intermediate monocyte: 20.7;non-classical monocyte: 26.1"	Lineage enriched	Detected in single	33	monocytes: 26.1	Group enriched	Detected in many	4	"liver cancer: 11.4;Myeloma: 14.9;thyroid cancer: 5.1"	Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Liver - Hepatocytes, Skin - Fibroblast_2, Spleen - Macrophages	Low region specificity	Detected in all			Low region specificity	Detected in many			CAB016775	Supported				Secreted to blood	Complement pathway	NA	NA	37800000000	24000000000	Cluster 40: Monocytes - Innate immune response	Cluster 83: Liver - Metabolism	Cluster 20: Macrophages & Microglia - Immune response	Cluster 51: Myeloma - Immunoglobulins	Cluster 62: Hepatocytes - Metabolism	7			CAB016775: 	unprognostic (6.99e-2)	unprognostic (1.25e-1)	unprognostic (5.40e-2)	unprognostic (2.08e-1)	unprognostic (2.16e-1)	unprognostic (1.13e-1)	unprognostic (4.52e-3)	unprognostic (2.12e-3)	unprognostic (5.54e-2)	unprognostic (2.85e-1)	unprognostic (1.40e-1)	unprognostic (5.22e-2)	unprognostic (1.96e-1)	unprognostic (5.24e-2)	unprognostic (1.03e-1)	unprognostic (4.20e-2)	unprognostic (5.88e-2)	unprognostic (6.55e-3)	unprognostic (1.59e-1)	unprognostic (1.54e-1)	unprognostic (1.11e-1)	unprognostic (1.47e-1)	unprognostic (1.86e-1)	unprognostic (8.71e-2)	unprognostic (3.94e-2)	unprognostic (8.60e-2)	unprognostic (2.09e-1)	unprognostic (1.66e-1)	unprognostic (1.70e-2)	unprognostic (1.01e-1)	unprognostic (4.70e-2)
C3	ARMD9, C3a, C3b, CPAMD1	ENSG00000125730	Complement C3	P01024	19	6677704-6730562	Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism		Age-related macular degeneration, Disease variant, FDA approved drug targets, Hemolytic uremic syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	9	liver: 5250.9	Cell type enhanced	Detected in many		"Ductal cells: 657.6;Exocrine glandular cells: 845.2;Hepatocytes: 3158.4;Mesothelial cells: 2220.5"	Cell type enriched	Detected in many	49	central nervous system macrophage: 753.0	Cancer enriched	Detected in all	4	Liver Hepatocellular Carcinoma (TCGA): 2175.6	Low region specificity	Detected in all			Immune cell enriched	Detected in many	5	non-classical monocyte: 14.5	Lineage enriched	Detected in many	5	monocytes: 14.5	Cancer enhanced	Detected in many		liver cancer: 255.0	Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Lung - Fibroblast_2, Pituitary gland - Macrophages, Thyroid gland - Macrophages	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA003563, CAB004209, HPA020432	Enhanced				Secreted to blood	Complement pathway	NA	NA	1,26E+12	2,2E+11	Cluster 40: Monocytes - Innate immune response	Cluster 83: Liver - Metabolism	Cluster 20: Macrophages & Microglia - Immune response	Cluster 53: Squamous epithelial cells - Keratinization	Cluster 62: Hepatocytes - Metabolism	40			CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118	unprognostic (2.65e-4)	unprognostic (3.98e-3)	unprognostic (1.16e-1)	unprognostic (5.34e-2)	unprognostic (6.78e-2)	unprognostic (7.28e-2)	unprognostic (1.25e-1)	unprognostic (3.60e-1)	unprognostic (9.50e-2)	unprognostic (1.92e-1)	unprognostic (3.62e-2)	unprognostic (1.84e-1)	unprognostic (2.59e-1)	unprognostic (1.94e-3)	unprognostic (6.67e-6)	unprognostic (1.50e-1)	unprognostic (3.09e-3)	unprognostic (3.82e-3)	unprognostic (6.46e-2)	unprognostic (2.70e-1)	unprognostic (3.19e-1)	unprognostic (8.47e-3)	unprognostic (1.95e-1)	unprognostic (6.60e-2)	unprognostic (1.04e-1)	unprognostic (1.27e-2)	unprognostic (1.37e-1)	unprognostic (9.78e-3)	unprognostic (1.65e-2)	unprognostic (1.74e-2)	unprognostic (8.98e-2)
C4BPA	C4BP	ENSG00000123838	Complement component 4 binding protein alpha	P04003	1	207104233-207144972	Human disease related genes, Plasma proteins, Predicted secreted proteins	Complement pathway, Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	11	liver: 1860.6	Group enriched	Detected in some	4	"Alveolar cells type 2: 321.7;Hepatocytes: 852.2"	Low cell type specificity	Detected in many			Group enriched	Detected in many	18	"Liver Hepatocellular Carcinoma (TCGA): 540.0;Lung Adenocarcinoma (TCGA): 144.5"	Low region specificity	Detected in many			Immune cell enriched	Detected in single	137	neutrophil: 29.6	Lineage enriched	Detected in single	137	granulocytes: 29.6	Cancer enhanced	Detected in some		"liver cancer: 7.4;lung cancer: 3.9"	Liver - Hepatocytes, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells	Not detected	Not detected			Region enhanced	Detected in single		midbrain: 1.6	HPA000926, HPA001578	Enhanced				Secreted to blood	Complement pathway	NA	NA	30800000000	33000000000	Cluster 4: Neutrophils - Degranulation	Cluster 83: Liver - Metabolism	Cluster 26: Oligodendrocytes - Mixed function	Cluster 72: Neuronal - Signal transduction	Cluster 62: Hepatocytes - Metabolism	5			HPA000926: AB_1078355, HPA001578: AB_1078354		unprognostic (2.04e-3)	unprognostic (1.30e-1)	unprognostic (9.20e-2)	unprognostic (4.28e-2)	unprognostic (2.96e-1)					unprognostic (4.36e-6)		unprognostic (7.43e-2)	unprognostic (5.71e-4)	unprognostic (1.64e-2)	unprognostic (2.49e-5)	unprognostic (2.87e-1)	unprognostic (1.23e-3)	unprognostic (2.68e-1)		unprognostic (8.24e-2)	unprognostic (3.68e-2)	unprognostic (1.35e-1)		unprognostic (1.17e-1)	unprognostic (1.64e-1)		unprognostic (1.41e-1)			unprognostic (1.10e-2)
C4BPB	C4BP	ENSG00000123843	Complement component 4 binding protein beta	P20851	1	207088860-207099993	Human disease related genes, Plasma proteins, Predicted secreted proteins	Complement pathway, Immunity, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	13	liver: 458.6	Cell type enriched	Detected in many	12	Hepatocytes: 654.1	Low cell type specificity	Detected in single			Cancer enriched	Detected in many	22	Liver Hepatocellular Carcinoma (TCGA): 272.1	Not detected	Not detected			Immune cell enhanced	Detected in single		plasmacytoid DC: 1.1	Low lineage specificity	Detected in single			Cancer enhanced	Detected in many		Bile duct cancer: 39.5	Adipose subcutaneous - Macrophages, Minor Salivary Gland - Minor salivary glandular cells, Testis - Late spermatids					Not detected	Not detected			HPA000925, HPA051620	Approved		Uncertain	Golgi apparatus	Secreted to blood	Complement pathway	NA	NA	2,65E+11	1400000000	Cluster 30: Non-specific - DNA binding	Cluster 31: Liver - Plasma proteins		Cluster 53: Squamous epithelial cells - Keratinization	Cluster 43: Hepatocytes - Metabolism	1	Golgi apparatus		HPA000925: , HPA051620: AB_2681554		unprognostic (1.24e-1)	unprognostic (1.03e-1)	unprognostic (1.89e-1)	unprognostic (2.15e-1)	unprognostic (1.77e-1)				unprognostic (2.67e-3)				unprognostic (8.51e-3)	unprognostic (6.63e-3)	unprognostic (8.74e-2)	unprognostic (2.46e-2)					unprognostic (2.60e-2)	unprognostic (1.46e-1)		unprognostic (4.08e-1)	unprognostic (2.29e-2)		unprognostic (2.92e-1)			unprognostic (3.22e-1)
C5	C5a, C5b, CPAMD4	ENSG00000106804	Complement C5	P01031	9	120932987-121075195	Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity		FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	30	liver: 434.4	Cell type enriched	Detected in many	14	Hepatocytes: 435.9	Low cell type specificity	Detected in all			Cancer enriched	Detected in many	10	Liver Hepatocellular Carcinoma (TCGA): 87.3	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	5	liver cancer: 21.1	Liver - Hepatocytes, Thyroid gland - Fibroblasts	Low region specificity	Detected in single			Low region specificity	Detected in many			HPA029339	Supported				Secreted to blood	Complement pathway	NA	NA	1,13E+11	41000000000		Cluster 83: Liver - Metabolism	Cluster 46: Brainstem - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	22			HPA029339: AB_10601125		unprognostic (3.76e-1)	unprognostic (1.10e-1)	unprognostic (4.64e-4)	unprognostic (9.13e-3)	unprognostic (7.89e-5)	unprognostic (1.56e-1)	unprognostic (2.11e-1)			unprognostic (1.84e-1)	unprognostic (1.07e-1)	unprognostic (1.60e-3)	unprognostic (5.22e-3)	unprognostic (2.32e-3)	unprognostic (3.04e-1)	unprognostic (9.93e-2)	unprognostic (9.13e-3)	unprognostic (3.72e-1)		unprognostic (2.47e-1)	unprognostic (4.98e-2)	unprognostic (1.29e-1)	unprognostic (6.90e-2)		unprognostic (1.46e-1)		unprognostic (6.11e-2)	unprognostic (2.29e-1)	unprognostic (1.01e-1)	
C6		ENSG00000039537	Complement C6	P13671	5	41142116-41261438	Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters	Complement pathway, Cytolysis, Immunity, Innate immunity		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	11	liver: 610.3	Cell type enhanced	Detected in some		"Cholangiocytes: 125.9;Ciliated cells: 63.9;Hepatocytes: 323.6;Late spermatids: 53.2;Leydig cells: 118.1"	Cell type enhanced	Detected in many		ependymal cell: 19.6	Cancer enhanced	Detected in many		Liver Hepatocellular Carcinoma (TCGA): 66.9	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		Bone cancer: 1.1	Liver - Hepatocytes, Lung - Respiratory ciliated cells, Minor Salivary Gland - Adipocytes (Minor salivary gland), Spleen - Fibroblast_2	Not detected	Not detected			Low region specificity	Detected in single			HPA043823, CAB069427	Enhanced				Secreted to blood	Complement pathway	NA	NA	45000000000	13000000000		Cluster 83: Liver - Metabolism	Cluster 3: Choroid plexus - Cilium	Cluster 44: Connective tissue cells - ECM organization	Cluster 62: Hepatocytes - Metabolism	3			CAB069427: AB_1614336, HPA043823: AB_10960262			unprognostic (1.98e-2)							unprognostic (1.18e-1)	unprognostic (2.11e-3)	unprognostic (3.95e-1)	unprognostic (7.40e-2)	unprognostic (2.51e-3)	unprognostic (4.58e-6)	unprognostic (6.13e-3)	unprognostic (1.85e-2)					unprognostic (1.96e-1)	unprognostic (2.30e-2)					unprognostic (8.11e-4)			unprognostic (4.96e-1)
C8A		ENSG00000157131	Complement C8 alpha chain	P07357	1	56854768-56918223	Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	279	liver: 481.7	Cell type enriched	Detected in some	14	Hepatocytes: 257.7	Not detected	Not detected			Cancer enriched	Detected in single	129	Liver Hepatocellular Carcinoma (TCGA): 90.1	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA077621			Supported	Plasma membrane	Secreted to blood	Complement pathway	NA	NA		10000000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	7	Plasma membrane		HPA077621: 														unprognostic (5.69e-3)	unprognostic (6.93e-7)																
C8B		ENSG00000021852	Complement C8 beta chain	P07358	1	56929207-56974383	Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	127	liver: 630.0	Cell type enriched	Detected in some	11	Hepatocytes: 247.1	Not detected	Not detected			Cancer enriched	Detected in some	98	Liver Hepatocellular Carcinoma (TCGA): 151.1	Not detected	Not detected			Immune cell enriched	Detected in single	23	basophil: 2.3	Lineage enriched	Detected in single	23	granulocytes: 2.3	Cancer enriched	Detected in single	11	liver cancer: 1.1	Liver - Hepatocytes, Minor Salivary Gland - Minor salivary glandular cells, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in all			HPA023694	Supported				Secreted to blood	Complement pathway	NA	NA		10000000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	1			HPA023694: AB_1847128			unprognostic (1.84e-2)											unprognostic (1.88e-4)	unprognostic (3.33e-8)	unprognostic (3.81e-3)	unprognostic (6.11e-2)														
C8G		ENSG00000176919	Complement C8 gamma chain	P07360	9	136945185-136946975	Human disease related genes, Plasma proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	18	liver: 550.5	Cell type enriched	Detected in some	9	Hepatocytes: 1036.6	Low cell type specificity	Detected in some			Cancer enriched	Detected in some	63	Liver Hepatocellular Carcinoma (TCGA): 273.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	"Gastric cancer: 6.2;liver cancer: 2.1"		Low region specificity	Detected in all			Low region specificity	Detected in all			HPA046269	Approved				Secreted to blood	Complement pathway	NA	NA		3600000000		Cluster 31: Liver - Plasma proteins		Cluster 57: Stomach & Colon cancer - Digestion	Cluster 62: Hepatocytes - Metabolism	3			HPA046269: AB_2679606			unprognostic (2.28e-1)		unprognostic (5.61e-2)									unprognostic (5.12e-4)	unprognostic (1.90e-2)							unprognostic (1.28e-1)	unprognostic (2.30e-1)		unprognostic (2.24e-1)			unprognostic (2.28e-1)			
C9		ENSG00000113600	Complement C9	P02748	5	39284140-39371324	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity		Age-related macular degeneration, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	264	liver: 1268.7	Cell type enriched	Detected in some	10	Hepatocytes: 1939.7	Cell type enhanced	Detected in many		"central nervous system macrophage: 7.2;fibroblast: 8.7"	Cancer enriched	Detected in some	72	Liver Hepatocellular Carcinoma (TCGA): 96.8	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in some			CAB002151, HPA029577	Uncertain				Secreted to blood	Complement pathway	NA	NA	69600000000	48000000000		Cluster 31: Liver - Plasma proteins		Cluster 59: Leukemia - T-cell receptor	Cluster 62: Hepatocytes - Metabolism	6			CAB002151: AB_563670, HPA029577: AB_10603779										unprognostic (1.09e-1)				unprognostic (1.47e-1)	unprognostic (2.45e-3)																
CCL16	CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4	ENSG00000275152	C-C motif chemokine ligand 16	O15467	17	35976493-35981497	Cancer-related genes, Plasma proteins, Predicted secreted proteins	Chemotaxis, Inflammatory response	Cytokine	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	45	liver: 116.5	Cell type enriched	Detected in some	71	Hepatocytes: 272.3	Not detected	Not detected			Cancer enriched	Detected in single	161	Liver Hepatocellular Carcinoma (TCGA): 43.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes					Low region specificity	Detected in many								Secreted to blood	Chemokine	NA	NA	2780000	29000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	2						unprognostic (4.52e-2)											unprognostic (4.52e-2)	unprognostic (1.60e-2)																
CFB	BF, BFD, H2-Bf	ENSG00000243649	Complement factor B	P00751	6	31945650-31952086	Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins	Complement alternate pathway, Immunity, Innate immunity	Hydrolase, Protease, Serine protease	Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	20	liver: 2453.1	Cell type enhanced	Detected in many		"Ductal cells: 913.7;Exocrine glandular cells: 569.1;Hepatocytes: 199.3;Mesothelial cells: 453.1;Pancreatic endocrine cells: 368.5"	Cell type enhanced	Detected in some		"endothelial cell: 5.7;vascular associated smooth muscle cell: 1.7"	Cancer enriched	Detected in all	7	Liver Hepatocellular Carcinoma (TCGA): 1256.7	Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	5	head and neck cancer: 34.6	Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Mesothelial cells, Liver - Hepatocytes, Minor Salivary Gland - Minor salivary glandular cells, Spleen - Fibroblast_1	Not detected	Not detected			Low region specificity	Detected in all			HPA000951, HPA001817, HPA001832, CAB016381	Supported		Approved	Endoplasmic reticulum,Vesicles,Cell Junctions	Secreted to blood	Immunity	NA	NA	879000000	1,1E+11		Cluster 83: Liver - Metabolism	Cluster 12: Non-specific - Vasculature	Cluster 53: Squamous epithelial cells - Keratinization	Cluster 45: Non-specific - Mixed function	5	Endoplasmic reticulum, Vesicles	Cell Junctions	CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778	unprognostic (5.49e-2)	unprognostic (4.40e-3)	unprognostic (3.23e-1)	unprognostic (5.23e-2)	unprognostic (4.18e-1)	unprognostic (2.43e-1)	unprognostic (3.73e-2)		unprognostic (1.35e-1)	unprognostic (1.24e-1)	unprognostic (4.67e-5)	unprognostic (8.00e-2)	unprognostic (4.88e-3)	unprognostic (7.40e-3)	unprognostic (2.67e-7)	unprognostic (2.88e-1)	unprognostic (1.46e-1)	unprognostic (1.25e-1)	unprognostic (1.26e-2)	unprognostic (2.32e-1)	unprognostic (6.23e-2)	unprognostic (1.16e-2)	unprognostic (1.36e-1)	unprognostic (1.34e-1)	unprognostic (3.57e-2)	unprognostic (7.08e-2)	unprognostic (2.88e-1)	unprognostic (1.87e-1)	unprognostic (1.01e-2)	unprognostic (1.67e-3)	unprognostic (3.70e-2)
CFH	ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS	ENSG00000000971	Complement factor H	P08603	1	196651754-196752476	Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity		Age-related macular degeneration, Cancer-related genes, Disease variant, Hemolytic uremic syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	6	liver: 1645.3	Cell type enhanced	Detected in many		"Fibroblasts: 355.9;Hepatocytes: 834.8;Leydig cells: 285.2;Mesothelial cells: 388.2;Ovarian stromal cells: 208.2"	Group enriched	Detected in many	7	"endothelial cell: 317.6;fibroblast: 269.5;pericyte: 401.5;vascular associated smooth muscle cell: 148.7"	Cancer enriched	Detected in all	9	Liver Hepatocellular Carcinoma (TCGA): 468.2	Region enhanced	Detected in all		choroid plexus: 43.6	Immune cell enhanced	Detected in some		MAIT T-cell: 17.6	Lineage enriched	Detected in single	56	T-cells: 17.6	Cancer enhanced	Detected in many		Gallbladder cancer: 59.2	Adrenal gland - Fibroblasts, Heart muscle - Fibroblasts, Liver - Hepatocytes, Lung - Fibroblast_2									CAB016385, CAB016769, HPA038922, HPA049176, HPA053326	Supported		Approved	Vesicles	Secreted to blood	Immunity	NA	NA	3,96E+11	1,3E+11	Cluster 1: T-cells - Unknown function	Cluster 83: Liver - Metabolism	Cluster 42: Choroid plexus - Mitochondria	Cluster 71: Lymphoma - Inflammatory response	Cluster 53: Fibroblasts - ECM organization	9	Vesicles		CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113	unprognostic (3.13e-1)	unprognostic (2.15e-1)	unprognostic (4.36e-1)	unprognostic (1.11e-1)	unprognostic (3.06e-1)	unprognostic (8.76e-2)	unprognostic (2.05e-3)	unprognostic (3.31e-4)	unprognostic (2.53e-1)	unprognostic (1.00e-1)	unprognostic (3.90e-3)	unprognostic (2.61e-2)	unprognostic (1.18e-1)	unprognostic (1.61e-3)	unprognostic (3.15e-3)	unprognostic (1.59e-1)	unprognostic (1.52e-2)	unprognostic (2.07e-1)	unprognostic (2.26e-2)	unprognostic (5.66e-2)	unprognostic (2.03e-2)	unprognostic (4.27e-2)	unprognostic (1.04e-1)	unprognostic (1.81e-1)	unprognostic (6.36e-2)	unprognostic (1.33e-1)	unprognostic (1.27e-2)	unprognostic (8.56e-3)	unprognostic (8.89e-3)	unprognostic (2.24e-1)	unprognostic (2.87e-2)
CFHR1	CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2	ENSG00000244414	Complement factor H related 1	Q03591	1	196819731-196837159	Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins			Cancer-related genes, Hemolytic uremic syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	224	liver: 2010.5	Cell type enhanced	Detected in some		"Granulosa cells: 65.7;Hepatocytes: 223.4;Kupffer cells: 55.4"	Cell type enhanced	Detected in single		MGE interneuron: 1.2	Cancer enriched	Detected in some	595	Liver Hepatocellular Carcinoma (TCGA): 781.2	Region enhanced	Detected in single		midbrain: 1.7	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		"Sarcoma: 3.3;thyroid cancer: 7.0"	Liver - Hepatocytes	Not detected	Not detected							HPA038915, HPA038922, HPA040726	Supported		Approved	Vesicles	Secreted to blood	Complement pathway	NA	NA	75000000000	16000000000		Cluster 31: Liver - Plasma proteins	Cluster 41: Monoamines - Neurotransmitter signalling	Cluster 16: Thyroid cancer - Neuronal signaling	Cluster 62: Hepatocytes - Metabolism	7	Vesicles		HPA038915: AB_2676269, HPA038922: AB_2676271, HPA040726: AB_2677101			unprognostic (8.31e-2)								unprognostic (3.58e-4)	unprognostic (7.84e-4)		unprognostic (1.25e-4)	unprognostic (6.51e-7)								unprognostic (1.90e-1)								
CFHR2	CFHL2, FHR2, HFL3	ENSG00000080910	Complement factor H related 2	P36980	1	196943738-196959622	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	2840	liver: 1309.3	Cell type enriched	Detected in some	26	Hepatocytes: 1227.2	Not detected	Not detected			Cancer enriched	Detected in single	638	Liver Hepatocellular Carcinoma (TCGA): 520.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes									HPA038915, HPA040726, HPA049813	Supported				Secreted to blood	Complement pathway	NA	NA	40000000000	4900000000		Cluster 31: Liver - Plasma proteins		Cluster 7: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	1			HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895														unprognostic (9.28e-4)	unprognostic (2.20e-4)																
CFHR3	CFHL3, DOWN16, FHR-3, FHR3, HLF4	ENSG00000116785	Complement factor H related 3	Q02985	1	196774813-196795407	Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins			Hemolytic uremic syndrome	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	982	liver: 381.0	Cell type enriched	Detected in some	6	Hepatocytes: 139.6	Cell type enhanced	Detected in some		"endothelial cell: 1.3;pericyte: 2.5"	Cancer enriched	Detected in single	65	Liver Hepatocellular Carcinoma (TCGA): 63.4	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		"Myeloma: 2.6;thyroid cancer: 2.8"										HPA077529			Approved	Vesicles	Secreted to blood	Complement pathway	NA	NA	582000000	3700000000		Cluster 31: Liver - Plasma proteins	Cluster 9: Non-specific - Receptor signaling	Cluster 16: Thyroid cancer - Neuronal signaling	Cluster 62: Hepatocytes - Metabolism	2	Vesicles		HPA077529: 			unprognostic (4.08e-1)											unprognostic (2.57e-5)	unprognostic (5.85e-9)		unprognostic (2.54e-1)		unprognostic (8.16e-2)												
CFHR4	CFHL4, FHR-4, FHR4	ENSG00000134365	Complement factor H related 4	Q92496	1	196888014-196918795	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	548	liver: 98.6	Cell type enriched	Detected in some	6	Hepatocytes: 36.6	Cell type enhanced	Detected in some		"deep-layer near-projecting: 2.4;MGE interneuron: 1.9"	Cancer enriched	Detected in single	166	Liver Hepatocellular Carcinoma (TCGA): 26.3	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes														Secreted to blood	Complement pathway	NA	NA	28000000000	270000000		Cluster 31: Liver - Plasma proteins		Cluster 51: Myeloma - Immunoglobulins	Cluster 62: Hepatocytes - Metabolism																		unprognostic (7.83e-7)	unprognostic (3.12e-5)																
CFHR5	CFHL5, FHR-5, FHR5	ENSG00000134389	Complement factor H related 5	Q9BXR6	1	196975010-197009678	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins			Disease variant, Hemolytic uremic syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	1620	liver: 162.0	Cell type enriched	Detected in some	21	Hepatocytes: 95.1	Cell type enriched	Detected in single	4	deep-layer near-projecting: 1.2	Cancer enriched	Detected in single	272	Liver Hepatocellular Carcinoma (TCGA): 61.2	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes									HPA038915, HPA040726	Supported				Secreted to blood	Complement pathway	NA	NA	2550000000	1900000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	15			HPA038915: AB_2676269, HPA040726: AB_2677101														unprognostic (1.09e-2)	unprognostic (1.42e-5)																
CFI	C3b-INA, FI, IF, KAF	ENSG00000205403	Complement factor I	P05156	4	109731008-109802150	Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins	Complement pathway, Host-virus interaction, Immunity, Innate immunity	Hydrolase, Protease, Serine protease	Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	liver: 952.1	Cell type enhanced	Detected in many		"Cholangiocytes: 108.7;Hepatocytes: 454.5;Muller glia cells: 114.1;Proximal tubular cells: 195.1"	Cell type enriched	Detected in some	6	endothelial cell: 68.4	Cancer enhanced	Detected in all		Liver Hepatocellular Carcinoma (TCGA): 187.9	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Adipose subcutaneous - Endothelial cells, Colon - Endothelial cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Spleen - Endothelial cells	Not detected	Not detected			Low region specificity	Detected in all			HPA001143, CAB016777, HPA024061	Supported				Secreted to blood	Complement pathway	NA	NA	30300000000	14000000000		Cluster 1: Liver & Kidney - Metabolism	Cluster 39: Astrocytes - Mixed function	Cluster 71: Lymphoma - Inflammatory response	Cluster 62: Hepatocytes - Metabolism	6			CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129	unprognostic (1.51e-1)	unprognostic (1.28e-1)	unprognostic (8.81e-2)	unprognostic (2.08e-2)	unprognostic (2.63e-1)	unprognostic (1.36e-1)	unprognostic (3.24e-3)	unprognostic (5.79e-2)	unprognostic (1.09e-1)	unprognostic (2.08e-2)	unprognostic (1.49e-3)	unprognostic (5.25e-4)	unprognostic (3.06e-1)	unprognostic (8.56e-2)	unprognostic (1.38e-4)	unprognostic (3.67e-1)	unprognostic (2.29e-1)	unprognostic (6.05e-2)	unprognostic (3.92e-2)	unprognostic (6.16e-2)	unprognostic (3.70e-2)	unprognostic (1.35e-1)	unprognostic (1.36e-1)	unprognostic (3.02e-1)	unprognostic (4.74e-2)	unprognostic (4.14e-1)	unprognostic (1.63e-2)	unprognostic (6.06e-2)	unprognostic (1.57e-1)	unprognostic (1.47e-1)	unprognostic (6.74e-2)
COLEC10	CL-10, CL-L1	ENSG00000184374	Collectin subfamily member 10	Q9Y6Z7	8	118995452-119108455	Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins			Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 63.7	Cell type enhanced	Detected in some		"Cardiomyocytes: 3.7;Excitatory neurons: 6.7;Inhibitory neurons: 5.2;Oligodendrocytes: 4.5;Oocytes: 23.5"	Cell type enhanced	Detected in many		mammillary body: 29.7	Cancer enhanced	Detected in some		Kidney Renal Papillary Cell Carcinoma (TCGA): 1.6	Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		"Kidney cancer: 7.8;Neuroblastoma: 8.8"	Liver - Hepatic stellate cells	Not detected	Not detected			Low region specificity	Detected in all								Secreted to blood	No annotated function	NA	NA	1870000000	66000000		Cluster 83: Liver - Metabolism	Cluster 52: Neurons & Synapses - Synaptic function	Cluster 64: Connective tissue cells - ECM organization	Cluster 50: Connective tissue cells - ECM organization							unprognostic (7.91e-2)									unprognostic (7.05e-2)	unprognostic (1.94e-1)	unprognostic (6.63e-4)	unprognostic (3.31e-3)																
CP	AB073614	ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149221829	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters		Oxidoreductase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	liver: 1815.4	Cell type enhanced	Detected in many		"Club cells: 294.5;Glandular and luminal cells: 433.6;Hepatocytes: 1419.3;Kupffer cells: 444.2;Muller glia cells: 594.4"	Group enriched	Detected in all	6	"choroid plexus epithelial cell: 361.5;ependymal cell: 209.6"	Cancer enhanced	Detected in many		Liver Hepatocellular Carcinoma (TCGA): 256.0	Region enriched	Detected in all	5	choroid plexus: 227.9	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		"Kidney cancer: 49.6;ovarian cancer: 45.2;Rhabdoid: 37.2"	Liver - Hepatocytes, Lung - Respiratory ciliated cells, Minor Salivary Gland - Minor salivary glandular cells	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA001834, CAB008591	Supported				Secreted to blood	Enzyme	NA	NA	1,6E+11	3,7E+11		Cluster 31: Liver - Plasma proteins	Cluster 36: Choroid plexus - Mixed function	Cluster 15: Kidney cancer - Membrane components	Cluster 62: Hepatocytes - Metabolism	11			CAB008591: AB_1613734, HPA001834: AB_1078502	unprognostic (9.77e-2)	unprognostic (2.70e-1)	unprognostic (5.24e-3)	unprognostic (1.54e-1)	unprognostic (2.61e-1)	unprognostic (1.27e-1)	unprognostic (2.12e-2)	unprognostic (1.53e-1)	unprognostic (1.67e-2)		unprognostic (1.03e-2)	unprognostic (1.20e-1)	unprognostic (1.15e-1)	unprognostic (8.21e-2)	unprognostic (1.40e-1)	unprognostic (2.03e-2)	unprognostic (5.64e-4)	unprognostic (2.62e-2)	unprognostic (4.26e-2)	unprognostic (1.61e-1)	unprognostic (3.36e-3)	unprognostic (7.63e-2)	unprognostic (6.72e-3)	unprognostic (3.08e-1)	unprognostic (8.24e-2)	unprognostic (2.90e-1)		unprognostic (7.16e-3)	unprognostic (1.12e-1)	unprognostic (1.16e-1)	unprognostic (8.07e-3)
CPB2	CPU, PCPB, TAFI	ENSG00000080618	Carboxypeptidase B2	Q96IY4	13	46053186-46105033	Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis	Carboxypeptidase, Hydrolase, Metalloprotease, Protease	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	84	liver: 1439.0	Cell type enriched	Detected in some	5	Hepatocytes: 1226.7	Cell type enhanced	Detected in many		oligodendrocyte: 87.4	Cancer enriched	Detected in some	60	Liver Hepatocellular Carcinoma (TCGA): 299.7	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	6	liver cancer: 11.2	Liver - Hepatocytes, Lung - Alveolar cells type 2	Not detected	Not detected			Low region specificity	Detected in some			HPA004146	Approved				Secreted to blood	Blood coagulation	NA	NA		6100000000		Cluster 31: Liver - Plasma proteins	Cluster 28: Oligodendrocytes - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism				HPA004146: AB_1078397			unprognostic (3.31e-1)											unprognostic (1.39e-4)	unprognostic (2.77e-3)	unprognostic (1.81e-2)	unprognostic (8.18e-2)						unprognostic (5.23e-3)			unprognostic (1.12e-1)					
CPN1		ENSG00000120054	Carboxypeptidase N subunit 1	P15169	10	100042193-100081869	Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins		Carboxypeptidase, Hydrolase, Metalloprotease, Protease	Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	55	liver: 79.5	Cell type enriched	Detected in some	4	Hepatocytes: 35.4	Not detected	Not detected			Group enriched	Detected in some	9	"Liver Hepatocellular Carcinoma (TCGA): 32.2;Skin Cuteneous Melanoma (TCGA): 19.5"	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	6	skin cancer: 35.3	Liver - Hepatocytes	Low region specificity	Detected in some			Not detected	Not detected								Secreted to blood	Enzyme	NA	NA		9500000000		Cluster 31: Liver - Plasma proteins		Cluster 69: Skin cancer - ECM organization	Cluster 62: Hepatocytes - Metabolism	4																	unprognostic (2.73e-2)	unprognostic (3.21e-2)												unprognostic (2.00e-1)		unprognostic (2.15e-1)		
CPN2	ACBP	ENSG00000178772	Carboxypeptidase N subunit 2	P22792	3	194339768-194351328	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	15	liver: 212.0	Cell type enriched	Detected in some	10	Hepatocytes: 143.8	Cell type enhanced	Detected in single		fibroblast: 1.1	Cancer enriched	Detected in some	24	Liver Hepatocellular Carcinoma (TCGA): 76.4	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	11	liver cancer: 7.5	Adipose visceral - Adipocytes (Visceral), Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in many			HPA004732	Uncertain				Secreted to blood	No annotated function	NA	NA	299000000	17000000000		Cluster 31: Liver - Plasma proteins	Cluster 9: Non-specific - Receptor signaling	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism				HPA004732: AB_1078561			unprognostic (2.19e-1)			unprognostic (5.28e-3)					unprognostic (1.75e-3)	unprognostic (2.11e-1)	unprognostic (9.31e-3)	unprognostic (5.91e-4)	unprognostic (8.69e-2)											unprognostic (8.75e-2)					
CRP	PTX1	ENSG00000132693	C-reactive protein	P02741	1	159712289-159714589	Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	80	liver: 9151.6	Group enriched	Detected in some	7	"Ductal cells: 1316.9;Hepatocytes: 3016.1"	Not detected	Not detected			Cancer enriched	Detected in many	11	Liver Hepatocellular Carcinoma (TCGA): 885.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		Gastric cancer: 1.1		Not detected	Not detected			Low region specificity	Detected in all			CAB005036, HPA027367, HPA027396	Supported		Approved	Nucleoplasm,Vesicles,Intermediate filaments	Secreted to blood	Acute phase	NA	NA	2920000000	3900000000		Cluster 31: Liver - Plasma proteins		Cluster 51: Myeloma - Immunoglobulins	Cluster 62: Hepatocytes - Metabolism	7	Nucleoplasm, Vesicles	Intermediate filaments	CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217	unprognostic (4.41e-2)		unprognostic (4.68e-1)	unprognostic (4.36e-1)							unprognostic (1.57e-3)	unprognostic (1.00e-1)	unprognostic (1.90e-2)	unprognostic (1.79e-1)	unprognostic (1.48e-1)							unprognostic (1.90e-2)	unprognostic (1.38e-3)				unprognostic (8.16e-3)	unprognostic (6.04e-2)			
CXCL2	CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, SCYB2	ENSG00000081041	C-X-C motif chemokine ligand 2	P19875	4	74097040-74099196	Cancer-related genes, Plasma proteins, Predicted secreted proteins	Chemotaxis, Inflammatory response	Cytokine	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	liver: 497.7	Cell type enhanced	Detected in many		"Alveolar cells type 2: 1419.5;Basal respiratory cells: 3098.3;Ionocytes: 2347.3;Langerhans cells: 2541.9;monocytes: 2355.2;Secretory cells: 2445.0"	Cell type enriched	Detected in some	5	endothelial cell: 89.8	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	6	"intermediate monocyte: 1.1;non-classical monocyte: 1.1"	Lineage enriched	Detected in single	10	monocytes: 1.1	Low cancer specificity	Detected in many			Pancreas - Ductal cells														Secreted to blood	Chemokine	NA	NA	500000			Cluster 83: Liver - Metabolism	Cluster 56: Hypothalamus - Neuropeptide signaling	Cluster 53: Squamous epithelial cells - Keratinization	Cluster 29: Monocytes - Innate immune response	5				unprognostic (7.21e-2)	unprognostic (8.78e-5)	unprognostic (1.70e-4)	unprognostic (2.23e-5)	unprognostic (1.69e-2)	unprognostic (1.05e-1)	unprognostic (8.96e-4)	unprognostic (1.07e-1)	unprognostic (7.55e-2)		unprognostic (1.15e-5)	unprognostic (4.02e-2)	unprognostic (1.23e-2)	unprognostic (6.95e-3)	unprognostic (2.25e-3)	unprognostic (1.17e-1)	unprognostic (1.34e-1)	unprognostic (1.01e-2)	unprognostic (1.29e-1)	unprognostic (2.21e-1)	unprognostic (2.21e-4)	unprognostic (1.37e-1)	unprognostic (2.41e-1)	unprognostic (5.61e-2)	unprognostic (1.52e-2)	unprognostic (2.98e-5)	unprognostic (1.14e-1)	unprognostic (2.31e-2)		unprognostic (1.80e-1)	unprognostic (3.45e-1)
EPO	EP	ENSG00000130427	Erythropoietin	P01588	7	100720468-100723700	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted secreted proteins	Erythrocyte maturation	Hormone	Cancer-related genes, Congenital erythrocytosis, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 46.0	Group enriched	Detected in some	4	"Exocrine glandular cells: 6.4;Extravillous trophoblasts: 16.8;Hepatocytes: 18.5"	Not detected	Not detected			Group enriched	Detected in some	8	"Kidney Renal Clear Cell Carcinoma (TCGA): 8.8;Liver Hepatocellular Carcinoma (TCGA): 2.2"	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		liver cancer: 1.0	Minor Salivary Gland - Minor salivary glandular cells	Not detected	Not detected			Not detected	Not detected			CAB010336	Supported				Secreted to blood	Hormone	NA	NA	12300			Cluster 83: Liver - Metabolism		Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	6			CAB010336: AB_2098408			unprognostic (3.40e-1)								unprognostic (1.20e-2)	unprognostic (3.65e-2)		unprognostic (1.37e-5)	unprognostic (4.32e-3)																
F11	FXI	ENSG00000088926	Coagulation factor XI	P03951	4	186266189-186289681	Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Heparin-binding, Hydrolase, Protease, Serine protease	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	liver: 235.6	Cell type enriched	Detected in some	7	Hepatocytes: 69.2	Cell type enriched	Detected in some	9	midbrain-derived inhibitory: 33.8	Cancer enriched	Detected in some	12	Liver Hepatocellular Carcinoma (TCGA): 39.8	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		liver cancer: 1.8	Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes, Lung - Alveolar cells type 2	Not detected	Not detected			Low region specificity	Detected in all			HPA039808			Approved	Vesicles	Secreted to blood	Blood coagulation	NA	NA		2800000000		Cluster 83: Liver - Metabolism	Cluster 38: Sub-cortical - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism		Vesicles		HPA039808: AB_2676693										unprognostic (1.91e-2)	unprognostic (4.70e-4)	unprognostic (2.90e-3)		unprognostic (7.02e-5)	unprognostic (2.94e-5)	unprognostic (4.03e-2)	unprognostic (6.51e-2)					unprognostic (6.81e-2)									
F12		ENSG00000131187	Coagulation factor XII	P00748	5	177402133-177416583	Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis	Hydrolase, Protease, Serine protease	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	311	liver: 589.9	Cell type enriched	Detected in many	5	Hepatocytes: 375.4	Cell type enhanced	Detected in many		hippocampal CA4: 19.9	Cancer enriched	Detected in many	100	Liver Hepatocellular Carcinoma (TCGA): 235.6	Not detected	Not detected			Immune cell enhanced	Detected in single		eosinophil: 1.7	Lineage enhanced	Detected in single		granulocytes: 1.7	Low cancer specificity	Detected in many			Kidney - Proximal tubular cells, Liver - Hepatocytes, Stomach - Mitotic cells (Stomach)	Low region specificity	Detected in single			Not detected	Not detected			HPA003825	Approved				Secreted to blood	Blood coagulation	NA	NA	1040000	7400000000	Cluster 19: Eosinophils - Unknown function	Cluster 31: Liver - Plasma proteins		Cluster 71: Lymphoma - Inflammatory response	Cluster 62: Hepatocytes - Metabolism	43			HPA003825: AB_1078790			unprognostic (3.27e-1)	unprognostic (1.13e-3)	unprognostic (8.05e-2)	unprognostic (1.01e-2)	unprognostic (7.21e-2)		unprognostic (3.11e-1)		unprognostic (9.57e-3)	unprognostic (6.14e-2)	unprognostic (2.25e-1)	unprognostic (8.62e-5)	unprognostic (8.20e-4)						unprognostic (4.44e-1)	unprognostic (3.54e-1)	unprognostic (9.99e-2)		unprognostic (4.05e-1)	unprognostic (1.14e-1)		unprognostic (1.13e-1)			
F13B	FXIIIB	ENSG00000143278	Coagulation factor XIII B chain	P05160	1	197038741-197067260	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Hemostasis		Cancer-related genes, Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	210	liver: 194.1	Cell type enriched	Detected in some	16	Hepatocytes: 59.1	Not detected	Not detected			Cancer enriched	Detected in single	496	Liver Hepatocellular Carcinoma (TCGA): 49.5	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA003827, HPA052139	Supported				Secreted to blood	Blood coagulation	NA	NA		4900000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	1			HPA003827: AB_1078794, HPA052139: AB_2681744														unprognostic (5.29e-5)	unprognostic (3.12e-2)																
F2		ENSG00000180210	Coagulation factor II, thrombin	P00734	11	46719196-46739506	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase, Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	1310	liver: 1180.6	Cell type enriched	Detected in some	7	Hepatocytes: 841.1	Low cell type specificity	Detected in single			Cancer enriched	Detected in some	87	Liver Hepatocellular Carcinoma (TCGA): 705.0	Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	10	liver cancer: 64.3	Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			CAB016780, HPA051476, HPA054698	Enhanced				Secreted to blood	Blood coagulation	NA	NA	1,08E+11	54000000000		Cluster 31: Liver - Plasma proteins	Cluster 15: Non-specific - Transcription	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	8			CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578											unprognostic (1.12e-6)	unprognostic (3.15e-4)		unprognostic (1.26e-1)	unprognostic (3.51e-3)	unprognostic (1.23e-4)												unprognostic (7.76e-3)	unprognostic (4.13e-1)		
F7		ENSG00000057593	Coagulation factor VII	P08709	13	113105788-113120685	Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	102	liver: 156.3	Cell type enriched	Detected in some	7	Hepatocytes: 119.3	Cell type enhanced	Detected in some		mammillary body: 1.2	Cancer enriched	Detected in some	16	Liver Hepatocellular Carcinoma (TCGA): 54.1	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		"breast cancer: 3.0;liver cancer: 8.7"	Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected								Secreted to blood	Blood coagulation	NA	NA	351000000	720000000		Cluster 31: Liver - Plasma proteins	Cluster 1: Neurons - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	3					unprognostic (7.22e-2)	unprognostic (9.92e-2)							unprognostic (3.40e-5)				unprognostic (4.23e-3)	unprognostic (1.77e-1)											unprognostic (1.50e-1)			unprognostic (1.68e-1)		
F9	FIX	ENSG00000101981	Coagulation factor IX	P00740	X	139530739-139563459	Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Disease variant, FDA approved drug targets, Hemophilia, Thrombophilia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	2448	liver: 683.7	Group enriched	Detected in some	12	"Hepatocytes: 519.8;Kupffer cells: 161.1"	Not detected	Not detected			Cancer enriched	Detected in single	706	Liver Hepatocellular Carcinoma (TCGA): 70.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected								Secreted to blood	Blood coagulation	NA	NA		5400000000		Cluster 31: Liver - Plasma proteins		Cluster 10: Ciliated cells - Ion channel activity	Cluster 62: Hepatocytes - Metabolism																		unprognostic (1.50e-3)	unprognostic (4.86e-5)																
FCN2	EBP-37, FCNL, ficolin-2, P35	ENSG00000160339	Ficolin 2	Q15485	9	134880810-134887523	Plasma proteins, Predicted secreted proteins	Complement activation lectin pathway, Immunity, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	liver: 96.6	Group enriched	Detected in some	9	"Endothelial cells: 71.9;Fibroblasts: 194.2;Kupffer cells: 75.4"	Not detected	Not detected			Cancer enhanced	Detected in some		Liver Hepatocellular Carcinoma (TCGA): 2.4	Not detected	Not detected			Immune cell enhanced	Detected in some		"classical monocyte: 5.5;intermediate monocyte: 4.6"	Low lineage specificity	Detected in many			Not detected	Not detected			Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Prostate - Prostate glandular cells					Region enriched	Detected in some	24	spinal cord: 51.0						Secreted to blood	Immunity	NA	NA	8100000000	910000000	Cluster 38: Monocytes & Neutrophils - Degranulation	Cluster 83: Liver - Metabolism		Cluster 10: Ciliated cells - Ion channel activity	Cluster 41: Adipocytes & Endothelial cells - Mixed function	4					unprognostic (2.73e-1)	unprognostic (3.78e-2)									unprognostic (2.36e-2)		unprognostic (3.69e-2)	unprognostic (3.53e-3)									unprognostic (7.98e-2)							
FETUB		ENSG00000090512	Fetuin B	Q9UGM5	3	186635969-186653141	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Fertilization	Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	27	liver: 227.3	Cell type enriched	Detected in some	6	Hepatocytes: 46.2	Not detected	Not detected			Cancer enriched	Detected in some	6	Liver Hepatocellular Carcinoma (TCGA): 38.1	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes, Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Not detected	Not detected			HPA035132, HPA035133	Supported		Approved	Vesicles	Secreted to blood	Enzyme inhibitor	NA	NA	47500000000	3000000000		Cluster 83: Liver - Metabolism		Cluster 53: Squamous epithelial cells - Keratinization	Cluster 43: Hepatocytes - Metabolism	6	Vesicles		HPA035132: AB_10601650, HPA035133: 				unprognostic (1.21e-2)					unprognostic (2.09e-1)					unprognostic (1.79e-2)	unprognostic (8.36e-3)			unprognostic (4.95e-3)	unprognostic (2.15e-1)												
FGA		ENSG00000171560	Fibrinogen alpha chain	P02671	4	154583126-154590742	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins	Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity		Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	386	liver: 17848.7	Cell type enriched	Detected in many	30	Hepatocytes: 13631.3	Not detected	Not detected			Cancer enriched	Detected in many	22	Liver Hepatocellular Carcinoma (TCGA): 4519.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	6	liver cancer: 180.5	Liver - Hepatocytes, Stomach - Parietal cells, Testis - Early spermatids, Testis - Late spermatids									CAB016776, HPA051370, HPA064755	Supported		Enhanced	Endoplasmic reticulum	Secreted to blood	Blood coagulation	NA	NA	407000000	1,6E+11		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	14	Endoplasmic reticulum		CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345		unprognostic (1.91e-1)	unprognostic (2.37e-1)	unprognostic (4.10e-2)							unprognostic (4.42e-2)	unprognostic (2.33e-2)	unprognostic (1.65e-2)	unprognostic (9.82e-4)	unprognostic (3.52e-3)	unprognostic (2.52e-2)	unprognostic (2.72e-1)	unprognostic (3.10e-5)	unprognostic (1.47e-1)			unprognostic (2.33e-1)	unprognostic (3.11e-5)		unprognostic (5.76e-2)		unprognostic (3.22e-1)	unprognostic (3.11e-1)	unprognostic (1.16e-1)		
FGB		ENSG00000171564	Fibrinogen beta chain	P02675	4	154563011-154572807	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity		Cancer-related genes, Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	372	liver: 17393.5	Cell type enriched	Detected in some	8	Hepatocytes: 15989.7	Not detected	Not detected			Cancer enriched	Detected in many	22	Liver Hepatocellular Carcinoma (TCGA): 3839.7	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	8	liver cancer: 219.4	Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA001900, HPA001901, CAB008624	Enhanced		Enhanced	Endoplasmic reticulum	Secreted to blood	Blood coagulation	NA	NA		1,3E+11		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	23	Endoplasmic reticulum		CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864		unprognostic (8.65e-2)	unprognostic (1.35e-2)	unprognostic (1.62e-2)							unprognostic (9.68e-2)	unprognostic (5.40e-2)	unprognostic (4.17e-2)	unprognostic (9.79e-3)	unprognostic (1.16e-3)	unprognostic (5.45e-3)	unprognostic (1.41e-1)	unprognostic (2.02e-1)				unprognostic (1.15e-1)	unprognostic (8.34e-9)		unprognostic (1.59e-1)		unprognostic (3.78e-1)	unprognostic (2.40e-2)	unprognostic (9.50e-2)		unprognostic (1.01e-1)
FGF21		ENSG00000105550	Fibroblast growth factor 21	Q9NSA1	19	48755524-48758333	Predicted secreted proteins, RAS pathway related proteins		Growth factor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	107	liver: 82.1	Group enriched	Detected in some	38	"Cholangiocytes: 1.9;Hepatocytes: 6.5"	Not detected	Not detected			Cancer enriched	Detected in single	384	Liver Hepatocellular Carcinoma (TCGA): 57.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		"Esophageal cancer: 1.6;Rhabdoid: 1.8"		Not detected	Not detected			Low region specificity	Detected in all			HPA061286	Supported				Secreted to blood	Growth factor	NA	NA	254000	140000		Cluster 31: Liver - Plasma proteins		Cluster 13: Non-specific - Mixed function	Cluster 43: Hepatocytes - Metabolism	6			HPA061286: AB_2684466														unprognostic (4.15e-2)	unprognostic (2.88e-3)																
FGG		ENSG00000171557	Fibrinogen gamma chain	P02679	4	154604134-154612967	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Hemostasis		Cancer-related genes, Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	330	liver: 16058.1	Cell type enriched	Detected in some	10	Hepatocytes: 9849.5	Not detected	Not detected			Cancer enriched	Detected in many	9	Liver Hepatocellular Carcinoma (TCGA): 3452.3	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	6	liver cancer: 229.6	Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA011159, HPA027529, CAB033120, HPA074638	Supported		Approved	Endoplasmic reticulum,Vesicles	Secreted to blood	Blood coagulation	NA	NA	2,67E+11	81000000000		Cluster 31: Liver - Plasma proteins		Cluster 71: Lymphoma - Inflammatory response	Cluster 62: Hepatocytes - Metabolism	6	Endoplasmic reticulum	Vesicles	CAB033120: AB_2103818, HPA011159: , HPA027529: AB_10601322, HPA074638: 		unprognostic (3.86e-2)	unprognostic (2.97e-1)	unprognostic (6.68e-2)							unprognostic (6.67e-2)	unprognostic (4.64e-3)	unprognostic (1.04e-1)	unprognostic (4.27e-3)	unprognostic (1.13e-2)	unprognostic (3.99e-2)	unprognostic (3.22e-1)	unprognostic (1.33e-4)	unprognostic (2.21e-1)			unprognostic (8.80e-3)	unprognostic (1.79e-4)					unprognostic (2.90e-3)	unprognostic (3.28e-1)		
FGL1	HFREP-1, HPS	ENSG00000104760	Fibrinogen like 1	Q08830	8	17864380-17910365	Plasma proteins, Predicted secreted proteins	Adaptive immunity, Immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 4058.4	Cell type enriched	Detected in some	10	Hepatocytes: 7048.4	Cell type enriched	Detected in some	8	central nervous system macrophage: 165.9	Cancer enriched	Detected in many	21	Liver Hepatocellular Carcinoma (TCGA): 1176.4	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	"Gastric cancer: 14.9;liver cancer: 57.2"	Testis - Early spermatids, Testis - Late spermatids	Low region specificity	Detected in many			Low region specificity	Detected in many								Secreted to blood	Immunity	NA	NA	33700000	81000000		Cluster 83: Liver - Metabolism	Cluster 53: Neurons - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	3					unprognostic (1.77e-1)	unprognostic (2.72e-2)								unprognostic (1.08e-4)			unprognostic (2.10e-1)	unprognostic (2.66e-1)	unprognostic (2.18e-1)	unprognostic (3.15e-1)	unprognostic (3.45e-2)				unprognostic (3.12e-1)	unprognostic (5.23e-3)	unprognostic (2.57e-3)				unprognostic (5.12e-4)			unprognostic (4.33e-2)
GC	DBP, hDBP, VDBP	ENSG00000145321	GC vitamin D binding protein	P02774	4	71741696-71804041	Metabolic proteins, Plasma proteins, Predicted secreted proteins	Transport	Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	17	liver: 8007.3	Group enriched	Detected in some	9	"Cholangiocytes: 1684.6;Hepatocytes: 2766.0"	Cell type enriched	Detected in some	4	ependymal cell: 8.5	Cancer enriched	Detected in many	15	Liver Hepatocellular Carcinoma (TCGA): 1502.8	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	17	liver cancer: 29.9	Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA001526, CAB008596, HPA019855	Supported				Secreted to blood	Transport	NA	NA	1,43E+11	1,1E+11		Cluster 83: Liver - Metabolism		Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism				CAB008596: AB_1622398, HPA001526: AB_1078959, HPA019855: AB_1849545											unprognostic (1.06e-1)	unprognostic (2.29e-2)	unprognostic (2.40e-3)	unprognostic (1.72e-3)	unprognostic (7.95e-2)							unprognostic (2.09e-3)	unprognostic (1.12e-3)	unprognostic (8.65e-4)				unprognostic (2.22e-2)			
GDF2	BMP-9, BMP9	ENSG00000263761	Growth differentiation factor 2	Q9UK05	10	47322454-47327588	Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins	Angiogenesis	Cytokine, Growth factor	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	134	liver: 18.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatic stellate cells	Not detected	Not detected			Low region specificity	Detected in many			CAB023357	Uncertain				Secreted to blood	Cytokine	NA	NA	2210000	1100000		Cluster 31: Liver - Plasma proteins	Cluster 51: Neurons - Mixed function	Cluster 47: Leukemia - Hemostasis	Cluster 41: Adipocytes & Endothelial cells - Mixed function	3			CAB023357: AB_2111086																															
GPLD1		ENSG00000112293	Glycosylphosphatidylinositol specific phospholipase D1	P80108	6	24424565-24495205	Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins	Lipid metabolism	Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	liver: 44.7	Cell type enhanced	Detected in many		"Cone photoreceptor cells: 49.3;Excitatory neurons: 60.4;Hepatocytes: 80.5;Inhibitory neurons: 75.0;Oligodendrocyte precursor cells: 31.1"	Low cell type specificity	Detected in all			Cancer enriched	Detected in some	7	Liver Hepatocellular Carcinoma (TCGA): 11.5	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		lymphoma: 6.3	Adipose visceral - Adipocytes (Visceral), Liver - Hepatocytes, Testis - Spermatogonia	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB008625, HPA012500	Uncertain				Secreted to blood	Enzyme	NA	NA	1,03E+11	2800000000		Cluster 83: Liver - Metabolism	Cluster 2: Neurons - Nucleosome	Cluster 71: Lymphoma - Inflammatory response	Cluster 43: Hepatocytes - Metabolism	2			CAB008625: AB_1621070, HPA012500: AB_1849931	unprognostic (2.57e-2)		unprognostic (1.76e-2)			unprognostic (1.45e-1)	unprognostic (3.53e-2)	unprognostic (2.43e-1)						unprognostic (1.11e-4)	unprognostic (1.50e-8)		unprognostic (2.17e-2)		unprognostic (1.43e-2)							unprognostic (2.21e-2)			unprognostic (3.01e-1)	unprognostic (5.36e-2)	
HABP2	FSAP, HABP, HGFAL, PHBP	ENSG00000148702	Hyaluronan binding protein 2	Q14520	10	113550837-113589602	Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins		Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	liver: 424.0	Cell type enhanced	Detected in some		"Cholangiocytes: 120.2;Ductal cells: 38.7;Hepatocytes: 185.7;Kupffer cells: 33.7;Oocytes: 85.3"	Cell type enhanced	Detected in some		"deep-layer near-projecting: 1.1;miscellaneous: 1.7;upper-layer intratelencephalic: 2.1"	Cancer enhanced	Detected in many		Liver Hepatocellular Carcinoma (TCGA): 128.0	Region enhanced	Detected in some		cerebral cortex: 2.3	Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	"Kidney cancer: 14.7;liver cancer: 19.4"	Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA019518	Uncertain				Secreted to blood	Enzyme	NA	NA	20200000000	5100000000		Cluster 31: Liver - Plasma proteins	Cluster 53: Neurons - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism				HPA019518: AB_1850467			unprognostic (1.07e-2)	unprognostic (6.74e-2)						unprognostic (2.68e-2)	unprognostic (1.18e-1)	unprognostic (2.82e-1)	unprognostic (3.18e-2)	unprognostic (1.19e-1)	unprognostic (3.34e-3)	unprognostic (2.45e-7)	unprognostic (3.98e-1)					unprognostic (7.84e-2)	unprognostic (1.88e-1)		unprognostic (1.33e-1)	unprognostic (1.10e-3)		unprognostic (1.28e-3)	unprognostic (2.64e-1)		unprognostic (1.95e-1)
HAMP	HEPC, HFE2B, LEAP-1, LEAP1	ENSG00000105697	Hepcidin antimicrobial peptide	P81172	19	35280716-35285143	Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters		Antibiotic, Antimicrobial, Fungicide, Hormone	Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	liver: 2003.9	Cell type enriched	Detected in some	15	Hepatocytes: 2832.2	Cell type enriched	Detected in single	35	central nervous system macrophage: 28.2	Group enriched	Detected in all	8	"Glioblastoma Multiforme (TCGA): 79.1;Liver Hepatocellular Carcinoma (TCGA): 191.9"	Region enhanced	Detected in all		medulla oblongata: 70.6	Group enriched	Detected in some	7	"myeloid DC: 1.5;plasmacytoid DC: 4.7"	Lineage enriched	Detected in single	10	dendritic cells: 4.7	Cancer enriched	Detected in some	5	liver cancer: 52.5	Pituitary gland - Macrophages	Not detected	Not detected			Not detected	Not detected								Secreted to blood	Hormone	NA	NA	1900000	15000000		Cluster 83: Liver - Metabolism	Cluster 12: Non-specific - Vasculature	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism					unprognostic (1.20e-1)	unprognostic (4.00e-3)	unprognostic (2.43e-2)	unprognostic (1.73e-5)	unprognostic (6.74e-4)		unprognostic (4.03e-2)	unprognostic (2.81e-1)	unprognostic (2.01e-1)	unprognostic (7.30e-2)	unprognostic (1.41e-5)	unprognostic (2.97e-5)	unprognostic (1.09e-1)	unprognostic (1.12e-1)	unprognostic (2.98e-1)	unprognostic (2.08e-1)	unprognostic (1.62e-2)	unprognostic (3.85e-2)	unprognostic (3.81e-2)	unprognostic (2.04e-1)	unprognostic (7.26e-2)	unprognostic (1.61e-1)	unprognostic (4.79e-1)	unprognostic (2.93e-1)	unprognostic (2.45e-1)		unprognostic (1.12e-3)	unprognostic (9.98e-2)	unprognostic (9.36e-2)	unprognostic (1.64e-2)	unprognostic (9.68e-2)
HGFAC	HGFA, HGFAP	ENSG00000109758	HGF activator	Q04756	4	3441968-3449486	Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins		Hydrolase, Protease, Serine protease	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	57	liver: 211.9	Group enriched	Detected in some	5	"Early spermatids: 75.5;Hepatocytes: 55.8;Late spermatids: 163.2"	Cell type enriched	Detected in some	8	CGE interneuron: 16.0	Cancer enriched	Detected in some	8	Liver Hepatocellular Carcinoma (TCGA): 29.3	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		thyroid cancer: 1.1		Not detected	Not detected			Low region specificity	Detected in many			HPA058279, HPA059076	Enhanced				Secreted to blood	Enzyme	NA	NA	7590000	5900000000		Cluster 31: Liver - Plasma proteins	Cluster 48: Non-specific - Mixed function	Cluster 16: Thyroid cancer - Neuronal signaling	Cluster 11: Late spermatids - Unknown function	5			HPA058279: AB_2683665, HPA059076: AB_2683898			unprognostic (1.54e-1)										unprognostic (7.13e-2)	unprognostic (3.67e-3)	unprognostic (8.94e-4)						unprognostic (1.54e-2)										
HP		ENSG00000257017	Haptoglobin	P00738	16	72054505-72061055	Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins	Acute phase, Immunity	Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog	Cancer-related genes, Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	85	liver: 54575.6	Group enriched	Detected in many	45	"Hepatocytes: 52816.7;Mesothelial cells: 16337.1"	Group enriched	Detected in some	5	"astrocyte: 2.3;bergmann glia: 3.3"	Cancer enriched	Detected in many	55	Liver Hepatocellular Carcinoma (TCGA): 12440.7	Region enhanced	Detected in all		medulla oblongata: 56.4	Group enriched	Detected in many	5	"classical monocyte: 49.5;eosinophil: 80.5"	Group enriched	Detected in many	7	"granulocytes: 80.5;monocytes: 49.5"	Group enriched	Detected in some	12	"Gastric cancer: 6.6;Leukemia: 4.1;liver cancer: 15.7"	Liver - Hepatocytes									CAB003787, HPA047750, HPA066795	Enhanced		Approved	Vesicles	Secreted to blood	Acute phase	NA	NA	9,98E+11	1,3E+11	Cluster 36: Eosinophils - Protein ubiquitination	Cluster 31: Liver - Plasma proteins	Cluster 12: Non-specific - Vasculature	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	22	Vesicles		CAB003787: , HPA047750: AB_2680146, HPA066795: 	unprognostic (1.68e-1)	unprognostic (4.89e-2)	unprognostic (7.23e-3)	unprognostic (2.66e-3)	unprognostic (2.15e-1)		unprognostic (2.13e-3)	unprognostic (4.18e-3)	unprognostic (3.91e-2)		unprognostic (1.13e-8)	unprognostic (6.87e-5)	unprognostic (1.16e-2)	unprognostic (4.94e-3)	unprognostic (7.31e-5)	unprognostic (3.05e-2)	unprognostic (3.47e-4)	unprognostic (1.77e-3)	unprognostic (2.61e-1)	unprognostic (1.04e-1)	unprognostic (1.35e-1)	unprognostic (1.67e-1)	unprognostic (4.65e-2)	unprognostic (1.94e-1)	unprognostic (1.96e-1)		unprognostic (1.89e-1)	unprognostic (3.68e-4)	unprognostic (1.40e-1)	unprognostic (2.08e-1)	unprognostic (8.82e-2)
HPR		ENSG00000261701	Haptoglobin-related protein	P00739	16	72063148-72077246	Enzymes, Plasma proteins, Predicted secreted proteins		Serine protease homolog		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in many	6	liver: 786.9	Cell type enriched	Detected in some	7	Hepatocytes: 205.7	Cell type enhanced	Detected in some		"astrocyte: 3.9;bergmann glia: 5.7"	Cancer enriched	Detected in some	49	Liver Hepatocellular Carcinoma (TCGA): 365.8	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	"liver cancer: 2.3;prostate cancer: 3.5"	Liver - Hepatocytes									HPA047750	Supported		Approved	Vesicles	Secreted to blood	Other	NA	NA	49000000000	67000000000		Cluster 83: Liver - Metabolism	Cluster 19: Astrocytes - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 15: Non-specific - Mixed function		Vesicles		HPA047750: AB_2680146			unprognostic (5.80e-2)				unprognostic (2.12e-1)	unprognostic (3.70e-1)			unprognostic (3.06e-6)		unprognostic (1.77e-2)	unprognostic (3.65e-3)	unprognostic (1.25e-4)																unprognostic (1.54e-1)
HPX		ENSG00000110169	Hemopexin	P02790	11	6431049-6442617	Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins	Host-virus interaction, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	886	liver: 5126.7	Cell type enriched	Detected in some	23	Hepatocytes: 4942.9	Low cell type specificity	Detected in many			Cancer enriched	Detected in some	71	Liver Hepatocellular Carcinoma (TCGA): 1427.5	Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		liver cancer: 9.0	Breast - Breast glandular cells, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			CAB016725, HPA065318, HPA068847	Approved				Secreted to blood	Transport	NA	NA	4,25E+11	2,3E+11		Cluster 31: Liver - Plasma proteins	Cluster 15: Non-specific - Transcription	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	13			CAB016725: , HPA065318: , HPA068847: 		unprognostic (6.59e-2)	unprognostic (2.34e-1)								unprognostic (4.62e-8)			unprognostic (3.62e-4)	unprognostic (6.11e-8)	unprognostic (1.06e-3)								unprognostic (1.89e-2)					unprognostic (3.55e-1)		
HRG	HPRG, HRGP	ENSG00000113905	Histidine rich glycoprotein	P04196	3	186660216-186678234	Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins	Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis	Heparin-binding	Disease variant, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	174	liver: 5270.7	Cell type enriched	Detected in some	11	Hepatocytes: 396.9	Not detected	Not detected			Cancer enriched	Detected in some	188	Liver Hepatocellular Carcinoma (TCGA): 1162.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA050269, HPA054598	Supported				Secreted to blood	Blood coagulation	NA	NA	1,2E+11	34000000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	11			HPA050269: AB_2681068, HPA054598: AB_2682539										unprognostic (1.12e-1)	unprognostic (7.50e-3)			unprognostic (4.11e-4)	unprognostic (4.20e-5)																
IGFALS	ALS	ENSG00000099769	Insulin like growth factor binding protein acid labile subunit	P35858	16	1790413-1794971	Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Cell adhesion		Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	11	liver: 113.8	Cell type enriched	Detected in some	6	Hepatocytes: 65.5	Not detected	Not detected			Cancer enhanced	Detected in many		Liver Hepatocellular Carcinoma (TCGA): 14.2	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in single			Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in many			HPA040692, HPA040948	Supported				Secreted to blood	Cell adhesion	NA	NA	14700000000	18000000000		Cluster 83: Liver - Metabolism	Cluster 6: Non-specific - Immune response	Cluster 15: Kidney cancer - Membrane components	Cluster 43: Hepatocytes - Metabolism	1			HPA040692: AB_10794067, HPA040948: AB_10794999		unprognostic (4.21e-3)	unprognostic (3.85e-1)	unprognostic (1.41e-2)	unprognostic (1.02e-1)	unprognostic (7.98e-3)								unprognostic (1.75e-3)	unprognostic (3.77e-6)	unprognostic (1.61e-5)				unprognostic (1.58e-1)		unprognostic (1.09e-1)				unprognostic (6.84e-2)		unprognostic (2.23e-1)		unprognostic (1.97e-1)	unprognostic (8.81e-3)
IGFBP1	AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12	ENSG00000146678	Insulin like growth factor binding protein 1	P08833	7	45888360-45893660	Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins		Growth factor binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 1163.6	Cell type enriched	Detected in some	9	Hepatocytes: 900.0	Cell type enhanced	Detected in single		lower rhombic lip: 1.1	Cancer enriched	Detected in many	16	Liver Hepatocellular Carcinoma (TCGA): 458.6	Low region specificity	Detected in some			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		"Gastric cancer: 38.2;liver cancer: 75.4;ovarian cancer: 50.4"	Breast - Breast glandular cells (progenitors), Kidney - Intercalated cells	Not detected	Not detected			Not detected	Not detected			CAB004445, HPA046972, HPA050640	Enhanced		Approved	Golgi apparatus	Secreted to blood	Other	NA	NA	28100000	28000000		Cluster 83: Liver - Metabolism	Cluster 49: Hindbrain - Mixed function	Cluster 15: Kidney cancer - Membrane components	Cluster 43: Hepatocytes - Metabolism	4	Golgi apparatus		CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197			unprognostic (4.54e-2)				unprognostic (9.54e-2)			unprognostic (1.55e-1)	unprognostic (8.65e-7)	unprognostic (5.58e-3)	unprognostic (8.89e-2)	unprognostic (6.59e-2)	unprognostic (4.08e-1)	unprognostic (1.39e-4)	unprognostic (1.56e-1)					unprognostic (1.17e-1)	unprognostic (1.76e-6)					unprognostic (3.01e-4)			unprognostic (5.35e-2)
IL1RAP	C3orf13, IL-1RAcP, IL1R3	ENSG00000196083	Interleukin 1 receptor accessory protein	Q9NPH3	3	190514051-190659750	Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins	Immunity, Inflammatory response, Innate immunity	Hydrolase, Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	6	liver: 218.9	Cell type enhanced	Detected in many		"Extravillous trophoblasts: 125.7;Hepatocytes: 315.4;Oligodendrocyte precursor cells: 280.2"	Cell type enhanced	Detected in all		oligodendrocyte precursor cell: 318.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	5	"eosinophil: 23.9;neutrophil: 95.8"	Lineage enriched	Detected in many	15	granulocytes: 95.8	Low cancer specificity	Detected in all			Skin - Keratinocyte (other)	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA035293	Uncertain		Approved	Vesicles,Cytosol	Secreted to blood	Receptor	NA	NA		240000000	Cluster 21: Neutrophils - Unknown function	Cluster 83: Liver - Metabolism	Cluster 51: Neurons - Mixed function	Cluster 71: Lymphoma - Inflammatory response	Cluster 43: Hepatocytes - Metabolism	10	Vesicles, Cytosol		HPA035293: AB_10671511	unprognostic (8.16e-5)	unprognostic (1.22e-1)	unprognostic (3.44e-1)	unprognostic (2.07e-1)	unprognostic (8.70e-2)	unprognostic (2.50e-1)	unprognostic (7.79e-2)	unprognostic (1.38e-4)	unprognostic (3.25e-2)	unprognostic (3.36e-3)	unprognostic (1.06e-3)	unprognostic (5.63e-2)	unprognostic (8.68e-4)	unprognostic (1.86e-2)	unprognostic (5.31e-3)	unprognostic (4.63e-2)	unprognostic (5.41e-4)	unprognostic (3.40e-1)	unprognostic (1.82e-1)	unprognostic (3.76e-1)	unprognostic (1.02e-3)	unprognostic (3.84e-4)	unprognostic (2.52e-2)	unprognostic (5.65e-2)	unprognostic (2.04e-1)	unprognostic (4.92e-2)	unprognostic (1.28e-1)	unprognostic (3.38e-3)	unprognostic (2.38e-1)	unprognostic (1.63e-1)	unprognostic (3.59e-3)
IL27	IL-27, IL-27A, IL27A, IL27p28, IL30, MGC71873, p28	ENSG00000197272	Interleukin 27	Q8NEV9	16	28499362-28512051	Predicted intracellular proteins, Predicted secreted proteins	Immunity, Inflammatory response, Innate immunity	Antiviral protein, Cytokine		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	15	liver: 26.1	Group enriched	Detected in some	6	"Hepatocytes: 16.5;Syncytiotrophoblasts: 31.1"	Cell type enhanced	Detected in some		"central nervous system macrophage: 1.5;deep-layer near-projecting: 1.3"	Cancer enriched	Detected in single	9	Liver Hepatocellular Carcinoma (TCGA): 7.1	Low region specificity	Detected in many			Immune cell enhanced	Detected in some		"classical monocyte: 3.6;intermediate monocyte: 3.8"	Low lineage specificity	Detected in many			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			CAB024722	Approved				Secreted to blood	Interleukin	NA	NA	521000		Cluster 38: Monocytes & Neutrophils - Degranulation	Cluster 83: Liver - Metabolism	Cluster 10: Cerebellum - Nucleic acid binding	Cluster 34: Testis cancer - Unknown function	Cluster 27: Syncytiotrophoblasts - Pregnancy	1			CAB024722: 			unprognostic (1.02e-1)											unprognostic (7.47e-4)	unprognostic (2.40e-3)																
INHBC		ENSG00000175189	Inhibin subunit beta C	P55103	12	57434784-57452062	Plasma proteins, Predicted secreted proteins		Growth factor, Hormone		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in single	171	liver: 159.9	Cell type enriched	Detected in some	9	Hepatocytes: 44.4	Not detected	Not detected			Cancer enriched	Detected in single	72	Liver Hepatocellular Carcinoma (TCGA): 35.2	Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		Myeloma: 4.9	Liver - Hepatocytes, Pituitary gland - Lactotropes, Testis - Early spermatids	Not detected	Not detected			Low region specificity	Detected in all			HPA050755			Approved	Cytosol	Secreted to blood	Hormone	NA	NA		23000000		Cluster 31: Liver - Plasma proteins	Cluster 37: Neurons - Mixed function	Cluster 51: Myeloma - Immunoglobulins	Cluster 62: Hepatocytes - Metabolism		Cytosol		HPA050755: 			unprognostic (2.90e-1)											unprognostic (7.41e-4)	unprognostic (1.09e-2)																
INHBE	activin, MGC4638	ENSG00000139269	Inhibin subunit beta E	P58166	12	57452323-57459280	Plasma proteins, Predicted secreted proteins		Growth factor, Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	96	liver: 144.2	Cell type enriched	Detected in some	4	Hepatocytes: 33.4	Cell type enhanced	Detected in single		bergmann glia: 2.0	Cancer enriched	Detected in some	20	Liver Hepatocellular Carcinoma (TCGA): 45.2	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	4	Myeloma: 76.4	Pituitary gland - Lactotropes, Skeletal muscle - Skeletal myocytes	Not detected	Not detected			Not detected	Not detected			HPA016843, CAB034017	Enhanced		Supported	Vesicles	Secreted to blood	Hormone	NA	NA		3200000		Cluster 31: Liver - Plasma proteins	Cluster 35: Non-specific - DNA binding	Cluster 13: Non-specific - Mixed function	Cluster 62: Hepatocytes - Metabolism	9	Vesicles		CAB034017: AB_2233745, HPA016843: AB_1851796			unprognostic (3.80e-1)								unprognostic (1.70e-8)	unprognostic (2.02e-4)	unprognostic (4.66e-2)	unprognostic (2.67e-1)	unprognostic (6.93e-3)																unprognostic (2.89e-2)
ITIH1	H1P, IATIH, ITIH	ENSG00000055957	Inter-alpha-trypsin inhibitor heavy chain 1	P19827	3	52777595-52792068	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	777	liver: 1459.7	Cell type enriched	Detected in some	23	Hepatocytes: 793.7	Not detected	Not detected			Cancer enriched	Detected in some	445	Liver Hepatocellular Carcinoma (TCGA): 658.9	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA041639, HPA042049	Approved		Approved	Vesicles	Secreted to blood	Enzyme inhibitor	NA	NA	4490000	95000000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	4	Vesicles		HPA041639: AB_10796349, HPA042049: AB_10797379			unprognostic (1.08e-1)								unprognostic (7.94e-3)			unprognostic (4.23e-4)	unprognostic (2.42e-3)																
ITIH2	H2P	ENSG00000151655	Inter-alpha-trypsin inhibitor heavy chain 2	P19823	10	7703316-7749520	Plasma proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	566	liver: 2091.1	Cell type enriched	Detected in some	4	Hepatocytes: 406.0	Cell type enriched	Detected in many	29	fibroblast: 184.1	Cancer enriched	Detected in many	273	Liver Hepatocellular Carcinoma (TCGA): 727.2	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in some	40	liver cancer: 147.1	Liver - Hepatocytes, Pituitary gland - Fibroblasts	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA059150	Supported		Approved	Golgi apparatus	Secreted to blood	Enzyme inhibitor	NA	NA		52000000000		Cluster 31: Liver - Plasma proteins	Cluster 16: Non-specific - Transcription	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	13	Golgi apparatus		HPA059150: AB_2683930			unprognostic (1.06e-1)				unprognostic (1.26e-1)	unprognostic (2.49e-2)			unprognostic (1.11e-4)			unprognostic (9.74e-4)	unprognostic (4.60e-2)	unprognostic (1.67e-1)	unprognostic (7.79e-2)			unprognostic (2.07e-2)		unprognostic (9.34e-2)	unprognostic (1.26e-2)					unprognostic (3.86e-3)	unprognostic (1.66e-1)		unprognostic (5.31e-3)
ITIH3	H3P	ENSG00000162267	Inter-alpha-trypsin inhibitor heavy chain 3	Q06033	3	52794768-52808799	Plasma proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	105	liver: 828.4	Group enriched	Detected in some	5	"Hepatocytes: 920.9;Kupffer cells: 562.7"	Cell type enriched	Detected in single	38	vascular associated smooth muscle cell: 20.2	Cancer enriched	Detected in some	163	Liver Hepatocellular Carcinoma (TCGA): 496.8	Low region specificity	Detected in some			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	12	liver cancer: 5.1	Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Heart muscle - Smooth muscle cells, Lung - Smooth muscle cells, Skeletal muscle - Smooth muscle cells, Testis - Late spermatids, Thyroid gland - Smooth muscle cells	Low region specificity	Detected in all			Low region specificity	Detected in some			HPA017373	Approved				Secreted to blood	Enzyme inhibitor	NA	NA		18000000000		Cluster 31: Liver - Plasma proteins	Cluster 32: Cerebral cortex - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism				HPA017373: AB_1851954			unprognostic (4.16e-1)								unprognostic (1.16e-4)			unprognostic (8.38e-2)	unprognostic (2.20e-6)						unprognostic (1.62e-1)	unprognostic (2.86e-1)	unprognostic (2.24e-2)								
ITIH4	H4P, IHRP, ITIHL1	ENSG00000055955	Inter-alpha-trypsin inhibitor heavy chain 4	Q14624	3	52812962-52830688	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase	Protease inhibitor, Serine protease inhibitor	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	38	liver: 1807.4	Group enriched	Detected in many	4	"Early spermatids: 68.4;Hepatocytes: 91.9;Late spermatids: 159.0"	Low cell type specificity	Detected in all			Cancer enriched	Detected in many	109	Liver Hepatocellular Carcinoma (TCGA): 562.1	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		liver cancer: 1.4	Adipose subcutaneous - Smooth muscle cells, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in many			HPA001835, HPA003948, CAB072872	Enhanced		Approved	Vesicles	Secreted to blood	Acute phase	NA	NA	3060000	83000000000		Cluster 31: Liver - Plasma proteins	Cluster 32: Cerebral cortex - Mixed function	Cluster 59: Leukemia - T-cell receptor	Cluster 62: Hepatocytes - Metabolism	1	Vesicles		CAB072872: AB_2665724, HPA001835: AB_1079432, HPA003948: AB_1079433			unprognostic (7.00e-2)	unprognostic (7.97e-3)			unprognostic (4.94e-2)		unprognostic (9.38e-2)		unprognostic (8.08e-9)	unprognostic (9.92e-3)		unprognostic (3.71e-2)	unprognostic (4.48e-8)	unprognostic (3.84e-3)	unprognostic (3.23e-1)				unprognostic (2.08e-2)	unprognostic (7.50e-3)	unprognostic (1.05e-1)					unprognostic (6.22e-4)	unprognostic (1.69e-1)		
KLKB1	KLK3	ENSG00000164344	Kallikrein B1	P03952	4	186226438-186258471	Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response	Hydrolase, Protease, Serine protease	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	28	liver: 318.1	Cell type enriched	Detected in many	4	Hepatocytes: 223.6	Cell type enhanced	Detected in all		astrocyte: 107.4	Cancer enriched	Detected in some	14	Liver Hepatocellular Carcinoma (TCGA): 38.4	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in many								Secreted to blood	Blood coagulation	NA	NA	28900000000	7400000000		Cluster 31: Liver - Plasma proteins	Cluster 23: Choroid plexus - Mixed function	Cluster 12: Bone cancer - Neuronal signaling	Cluster 62: Hepatocytes - Metabolism	9						unprognostic (4.54e-2)								unprognostic (7.10e-2)	unprognostic (7.11e-3)	unprognostic (3.86e-2)	unprognostic (7.41e-3)	unprognostic (2.00e-4)							unprognostic (8.94e-3)									
KNG1	BDK, BK, HK, HMWK, KNG	ENSG00000113889	Kininogen 1	P01042	3	186717348-186744410	Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis, Inflammatory response	Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	liver: 3097.3	Cell type enriched	Detected in some	6	Hepatocytes: 1654.3	Cell type enhanced	Detected in single		oligodendrocyte precursor cell: 1.2	Cancer enriched	Detected in some	21	Liver Hepatocellular Carcinoma (TCGA): 1157.6	Low region specificity	Detected in single			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	11	"Gastric cancer: 4.6;liver cancer: 8.0"	Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in single			HPA001616, HPA001645, CAB009809	Enhanced				Secreted to blood	Blood coagulation	NA	NA	90000000000	49000000000		Cluster 1: Liver & Kidney - Metabolism	Cluster 53: Neurons - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	2			CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215			unprognostic (9.44e-2)							unprognostic (1.27e-1)	unprognostic (8.94e-2)	unprognostic (2.97e-1)	unprognostic (2.60e-3)	unprognostic (2.11e-7)	unprognostic (2.33e-4)														unprognostic (1.63e-1)		
LBP	BPIFD2	ENSG00000129988	Lipopolysaccharide binding protein	P18428	20	38346482-38377013	Plasma proteins, Predicted secreted proteins, Transporters	Immunity, Innate immunity, Lipid transport, Transport	Antibiotic, Antimicrobial		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	23	liver: 1304.6	Cell type enriched	Detected in some	14	Hepatocytes: 388.2	Not detected	Not detected			Cancer enriched	Detected in many	12	Liver Hepatocellular Carcinoma (TCGA): 407.5	Region enhanced	Detected in single		medulla oblongata: 2.2	Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	8	"Brain cancer: 6.7;breast cancer: 2.7;liver cancer: 2.3;lymphoma: 1.8;thyroid cancer: 2.9"	Kidney - Proximal tubular cells, Thyroid gland - Macrophages	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA001508, CAB025905	Approved				Secreted to blood	Transport	NA	NA	25000000000	1900000000		Cluster 31: Liver - Plasma proteins	Cluster 39: Astrocytes - Mixed function	Cluster 71: Lymphoma - Inflammatory response	Cluster 62: Hepatocytes - Metabolism	2			CAB025905: , HPA001508: AB_1079241		unprognostic (1.60e-1)	unprognostic (3.87e-3)	unprognostic (3.07e-2)			unprognostic (1.00e-2)				unprognostic (1.81e-6)	unprognostic (1.28e-5)	unprognostic (1.52e-4)	unprognostic (2.31e-2)	unprognostic (1.06e-1)	unprognostic (6.63e-3)		unprognostic (3.92e-3)				unprognostic (1.02e-1)					unprognostic (6.88e-2)	unprognostic (1.06e-3)			unprognostic (2.03e-1)
LEAP2	LEAP-2	ENSG00000164406	Liver enriched antimicrobial peptide 2	Q969E1	5	132873444-132875046	Plasma proteins, Predicted secreted proteins		Antibiotic, Antimicrobial		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	23	liver: 514.5	Cell type enriched	Detected in many	6	Hepatocytes: 1795.3	Low cell type specificity	Detected in many			Cancer enriched	Detected in some	31	Liver Hepatocellular Carcinoma (TCGA): 124.1	Low region specificity	Detected in all			Low immune cell specificity	Detected in many			Low lineage specificity	Detected in many			Low cancer specificity	Detected in some				Not detected	Not detected			Low region specificity	Detected in all								Secreted to blood	Defense	NA	NA		1600000	Cluster 20: Non-specific - DNA binding	Cluster 83: Liver - Metabolism	Cluster 48: Non-specific - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	4				unprognostic (2.18e-1)		unprognostic (1.75e-1)								unprognostic (1.70e-5)	unprognostic (3.44e-3)	unprognostic (2.42e-1)	unprognostic (4.94e-3)	unprognostic (4.67e-5)						unprognostic (1.90e-2)							unprognostic (5.45e-2)			
LECT2	chm-II, chm2	ENSG00000145826	Leukocyte cell derived chemotaxin 2	O14960	5	135922279-135954983	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Chemotaxis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	54	liver: 461.9	Group enriched	Detected in some	22	"Early spermatids: 170.6;Hepatocytes: 115.6;Late spermatids: 59.4"	Cell type enhanced	Detected in some		"eccentric medium spiny neuron: 14.0;midbrain-derived inhibitory: 9.2"	Cancer enriched	Detected in some	58	Liver Hepatocellular Carcinoma (TCGA): 86.0	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in some			Liver - Hepatocytes, Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected			Low region specificity	Detected in many			HPA043883, HPA058246	Enhanced		Supported	Vesicles,Cytosol	Secreted to blood	Other	NA	NA	26500000	4000000		Cluster 31: Liver - Plasma proteins	Cluster 10: Cerebellum - Nucleic acid binding	Cluster 56: Non-specific - Sensory perception	Cluster 43: Hepatocytes - Metabolism		Cytosol	Vesicles	HPA043883: AB_2678714, HPA058246: 						unprognostic (1.01e-2)						unprognostic (1.15e-1)		unprognostic (3.72e-5)	unprognostic (8.75e-3)											unprognostic (1.14e-1)		unprognostic (8.92e-2)			
LIPC	HL, HTGL	ENSG00000166035	Lipase C, hepatic type	P11150	15	58410569-58569844	Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins	Lipid degradation, Lipid metabolism	Heparin-binding, Hydrolase	Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	29	liver: 165.9	Cell type enriched	Detected in some	7	Hepatocytes: 149.3	Cell type enhanced	Detected in many		"central nervous system macrophage: 83.7;oligodendrocyte: 29.0"	Group enriched	Detected in many	18	"Kidney Renal Clear Cell Carcinoma (TCGA): 17.5;Kidney Renal Papillary Cell Carcinoma (TCGA): 59.5;Liver Hepatocellular Carcinoma (TCGA): 56.7"	Low region specificity	Detected in all			Low immune cell specificity	Detected in some			Group enriched	Detected in many	7	"granulocytes: 1.7;NK-cells: 1.5;T-cells: 1.8"	Group enriched	Detected in many	5	"Gastric cancer: 22.7;Kidney cancer: 6.3;liver cancer: 18.6"	Liver - Hepatocytes, Minor Salivary Gland - Fibroblasts, Pituitary gland - Gonadotropes, Skin - Fibroblast_1	Not detected	Not detected			Low region specificity	Detected in many								Secreted to blood	Enzyme	NA	NA		16000000	Cluster 33: Non-specific - ATP binding	Cluster 31: Liver - Plasma proteins	Cluster 37: Neurons - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism					unprognostic (5.29e-2)		unprognostic (3.94e-2)		unprognostic (2.64e-1)					unprognostic (7.22e-2)	unprognostic (7.32e-3)	unprognostic (1.22e-1)	unprognostic (7.39e-2)	unprognostic (1.16e-2)	unprognostic (2.31e-2)							unprognostic (3.16e-1)	unprognostic (2.08e-1)					unprognostic (1.60e-1)	unprognostic (3.74e-2)		
LPA	LP, Lp(a)	ENSG00000198670	Lipoprotein(a)	P08519	6	160531482-160664275	Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Lipid transport, Transport	Hydrolase, Protease, Serine protease	Atherosclerosis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	65	liver: 74.5	Cell type enriched	Detected in some	6	Hepatocytes: 34.5	Low cell type specificity	Detected in many			Cancer enriched	Detected in single	16	Liver Hepatocellular Carcinoma (TCGA): 4.0	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Kidney - Proximal tubular cells, Liver - Hepatocytes									CAB016072, HPA060604	Supported				Secreted to blood	Transport	NA	NA	78800000000	15000000000		Cluster 31: Liver - Plasma proteins	Cluster 56: Hypothalamus - Neuropeptide signaling	Cluster 59: Leukemia - T-cell receptor	Cluster 62: Hepatocytes - Metabolism	7			CAB016072: AB_2135240, HPA060604: AB_2684330														unprognostic (7.33e-4)	unprognostic (1.13e-3)																
LRG1	LRG	ENSG00000171236	Leucine rich alpha-2-glycoprotein 1	P02750	19	4536402-4540036	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	21	liver: 920.6	Cell type enriched	Detected in many	5	Hepatocytes: 621.6	Not detected	Not detected			Cancer enriched	Detected in many	7	Liver Hepatocellular Carcinoma (TCGA): 191.6	Low region specificity	Detected in all			Immune cell enriched	Detected in many	19	neutrophil: 285.0	Lineage enriched	Detected in many	45	granulocytes: 285.0	Low cancer specificity	Detected in many			Adipose visceral - Neutrophils, Adrenal gland - Neutrophils, Heart muscle - Neutrophils, Minor Salivary Gland - Minor salivary glandular cells, Spleen - Neutrophils	Low region specificity	Detected in single							HPA001888, HPA001889	Enhanced		Approved	Vesicles	Secreted to blood	No annotated function	NA	NA	21000000000	26000000000	Cluster 4: Neutrophils - Degranulation	Cluster 83: Liver - Metabolism	Cluster 48: Non-specific - Mixed function	Cluster 71: Lymphoma - Inflammatory response	Cluster 62: Hepatocytes - Metabolism	7	Vesicles		HPA001888: AB_1079276, HPA001889: AB_1079275	unprognostic (1.85e-1)	unprognostic (2.58e-2)	unprognostic (3.38e-1)	unprognostic (2.08e-1)	unprognostic (4.79e-2)	unprognostic (8.37e-2)			unprognostic (1.44e-1)		unprognostic (4.18e-3)	unprognostic (7.75e-2)	unprognostic (1.58e-3)	unprognostic (4.69e-2)	unprognostic (3.52e-5)	unprognostic (4.36e-2)	unprognostic (9.36e-2)	unprognostic (1.34e-1)	unprognostic (3.40e-2)	unprognostic (7.55e-2)	unprognostic (1.02e-1)	unprognostic (9.36e-4)	unprognostic (3.22e-1)	unprognostic (1.98e-1)	unprognostic (2.64e-1)	unprognostic (5.47e-3)	unprognostic (1.68e-1)	unprognostic (7.45e-2)	unprognostic (1.15e-1)	unprognostic (3.01e-3)	unprognostic (2.03e-2)
MASP2	MAP-2, Map19, MASP1P1, sMAP	ENSG00000009724	MBL associated serine protease 2	O00187	1	11022009-11047239	Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins	Complement pathway, Immunity, Innate immunity	Hydrolase, Protease, Serine protease	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	57	liver: 464.7	Cell type enriched	Detected in some	47	Hepatocytes: 634.2	Low cell type specificity	Detected in all			Cancer enriched	Detected in some	151	Liver Hepatocellular Carcinoma (TCGA): 204.2	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA029313, HPA029314	Uncertain		Supported	Golgi apparatus	Secreted to blood	Complement pathway	NA	NA	340000000	690000000		Cluster 83: Liver - Metabolism	Cluster 2: Neurons - Nucleosome	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	6	Golgi apparatus		HPA029313: AB_10669654, HPA029314: AB_10670029			unprognostic (2.92e-1)			unprognostic (1.48e-1)	unprognostic (1.61e-1)							unprognostic (1.20e-3)	unprognostic (5.95e-4)		unprognostic (9.22e-2)									unprognostic (4.04e-1)					
MBL2	COLEC1, MBL, MBP, MBP-C, MBP1	ENSG00000165471	Mannose binding lectin 2	P11226	10	52765380-52772784	Human disease related genes, Plasma proteins, Predicted secreted proteins	Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	2727	liver: 272.6	Cell type enriched	Detected in some	98	Hepatocytes: 230.9	Not detected	Not detected			Cancer enriched	Detected in single	234	Liver Hepatocellular Carcinoma (TCGA): 23.4	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	5	liver cancer: 1.0	Liver - Hepatocytes	Not detected	Not detected			Region enriched	Detected in single	13	basal ganglia: 1.3	HPA002027, CAB016782	Enhanced				Secreted to blood	Complement pathway	NA	NA	1220000000	1400000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	27			CAB016782: , HPA002027: AB_1079324														unprognostic (1.28e-2)	unprognostic (1.11e-6)																
MST1	D3F15S2, DNF15S2, HGFL, MSP, NF15S2	ENSG00000173531	Macrophage stimulating 1		3	49683947-49689501	Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins			Cancer-related genes	Evidence at protein level	Evidence at protein level			Tissue enriched	Detected in all	10	liver: 905.4	Cell type enhanced	Detected in many		"Hepatocytes: 196.0;Mesothelial cells: 44.6;Proximal enterocytes: 54.0;Proximal tubular cells: 42.5"	Cell type enhanced	Detected in all		astrocyte: 20.9	Cancer enriched	Detected in all	7	Liver Hepatocellular Carcinoma (TCGA): 154.1	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Adipose visceral - Mesothelial cells, Kidney - Proximal tubular cells, Skeletal muscle - Fibroblasts	Not detected	Not detected			Low region specificity	Detected in all			HPA024036, HPA068514, CAB080358	Approved		Approved	Vesicles	Secreted to blood		NA	NA				Cluster 1: Liver & Kidney - Metabolism	Cluster 15: Non-specific - Transcription	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	2	Vesicles		CAB080358: , HPA024036: AB_1854147, HPA068514: 	unprognostic (4.43e-2)	unprognostic (1.78e-2)	unprognostic (6.33e-2)	unprognostic (9.42e-2)	unprognostic (1.62e-1)	unprognostic (1.98e-2)	unprognostic (2.80e-1)		unprognostic (1.02e-2)	unprognostic (1.04e-1)	unprognostic (3.72e-3)	unprognostic (1.20e-1)	unprognostic (9.24e-3)	unprognostic (1.21e-2)	unprognostic (6.57e-2)	unprognostic (1.83e-2)	unprognostic (7.74e-2)	unprognostic (7.85e-2)	unprognostic (7.19e-2)	unprognostic (1.47e-1)	unprognostic (5.78e-2)	unprognostic (5.36e-3)	unprognostic (2.77e-1)	unprognostic (3.00e-2)	unprognostic (5.66e-2)	unprognostic (5.12e-2)	unprognostic (9.45e-2)	unprognostic (3.80e-1)	unprognostic (3.10e-1)	unprognostic (1.84e-1)	unprognostic (2.02e-1)
OIT3	FLJ39116, LZP	ENSG00000138315	Oncoprotein induced transcript 3	Q8WWZ8	10	72893584-72933036	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	14	liver: 107.5	Group enriched	Detected in some	8	"Endothelial cells: 96.8;Fibroblasts: 45.0;Kupffer cells: 61.7"	Cell type enhanced	Detected in many		upper rhombic lip: 6.3	Cancer enhanced	Detected in some		Liver Hepatocellular Carcinoma (TCGA): 5.1	Region enhanced	Detected in some		cerebellum: 2.9	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	4	liver cancer: 1.3	Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Testis - Early spermatids	Not detected	Not detected			Not detected	Not detected								Secreted to blood	No annotated function	NA	NA		70000000		Cluster 31: Liver - Plasma proteins	Cluster 35: Non-specific - DNA binding	Cluster 1: Neuronal - Visual perception	Cluster 41: Adipocytes & Endothelial cells - Mixed function	9						unprognostic (3.28e-2)								unprognostic (3.89e-8)	unprognostic (2.88e-6)		unprognostic (5.33e-2)	unprognostic (3.59e-2)										unprognostic (4.31e-2)				unprognostic (2.48e-1)	unprognostic (9.55e-3)	
ORM1		ENSG00000229314	Orosomucoid 1	P02763	9	114323098-114326479	Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Acute phase, Transport		Cancer-related genes, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	177	liver: 41892.9	Cell type enriched	Detected in some	53	Hepatocytes: 54806.5	Not detected	Not detected			Cancer enriched	Detected in many	13	Liver Hepatocellular Carcinoma (TCGA): 6498.2	Low region specificity	Detected in single			Immune cell enriched	Detected in some	47	neutrophil: 201.8	Lineage enriched	Detected in many	47	granulocytes: 201.8	Cancer enriched	Detected in many	4	liver cancer: 243.4	Liver - Hepatocytes, Lung - Neutrophil_2									CAB006265, HPA046438, HPA047725, HPA057726	Approved		Approved	Golgi apparatus,Vesicles	Secreted to blood	Acute phase	NA	NA	9,45E+11	45000000000	Cluster 4: Neutrophils - Degranulation	Cluster 31: Liver - Plasma proteins	Cluster 54: Immune cells - T cell receptor	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	22	Vesicles	Golgi apparatus	CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512		unprognostic (3.93e-2)	unprognostic (1.23e-1)	unprognostic (3.16e-3)	unprognostic (9.91e-3)	unprognostic (1.90e-2)					unprognostic (1.99e-2)			unprognostic (2.80e-1)	unprognostic (1.06e-3)	unprognostic (6.76e-2)	unprognostic (1.88e-1)	unprognostic (3.21e-2)	unprognostic (1.15e-1)	unprognostic (1.14e-1)	unprognostic (2.19e-1)	unprognostic (2.59e-3)	unprognostic (3.21e-2)	unprognostic (1.77e-1)	unprognostic (1.13e-1)	unprognostic (1.32e-1)	unprognostic (6.24e-1)	unprognostic (1.21e-1)	unprognostic (1.98e-2)	unprognostic (1.40e-2)	unprognostic (9.18e-2)
ORM2	AGP-B, AGP-B', AGP2	ENSG00000228278	Orosomucoid 2	P19652	9	114329869-114333251	FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Acute phase, Transport		FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	297	liver: 8652.9	Cell type enriched	Detected in some	44	Hepatocytes: 9678.3	Not detected	Not detected			Cancer enriched	Detected in many	34	Liver Hepatocellular Carcinoma (TCGA): 1922.8	Low region specificity	Detected in some			Immune cell enriched	Detected in single	39	neutrophil: 13.2	Lineage enriched	Detected in single	39	granulocytes: 13.2	Cancer enriched	Detected in some	27	liver cancer: 95.6	Liver - Hepatocytes, Testis - Late spermatids									HPA046438, HPA047725, HPA057726	Approved		Approved	Golgi apparatus,Vesicles	Secreted to blood	Acute phase	NA	NA	422000000	29000000000	Cluster 4: Neutrophils - Degranulation	Cluster 31: Liver - Plasma proteins	Cluster 33: Neurons - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	5	Vesicles	Golgi apparatus	HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512		unprognostic (7.46e-3)	unprognostic (3.41e-1)								unprognostic (5.58e-6)			unprognostic (7.37e-2)	unprognostic (6.31e-3)	unprognostic (1.30e-1)	unprognostic (9.43e-3)	unprognostic (1.20e-2)	unprognostic (1.04e-1)	unprognostic (2.26e-1)		unprognostic (6.38e-3)	unprognostic (5.45e-1)	unprognostic (5.21e-2)	unprognostic (1.30e-1)		unprognostic (6.66e-1)	unprognostic (3.30e-1)			unprognostic (5.20e-1)
PCSK9	FH3, HCHOLA3, NARC-1	ENSG00000169174	Proprotein convertase subtilisin/kexin type 9	Q8NBP7	1	55039447-55064852	Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Apoptosis, Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism	Hydrolase, Protease, Serine protease	Disease variant, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 47.6	Group enriched	Detected in some	4	"Alveolar cells type 2: 31.1;Hepatocytes: 28.2;Kupffer cells: 13.4"	Group enriched	Detected in some	5	"lower rhombic lip: 10.3;upper rhombic lip: 8.0"	Low cancer specificity	Detected in many			Group enriched	Detected in some	6	"cerebellum: 7.1;medulla oblongata: 1.8;pons: 4.4"	Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Lung - Alveolar cells type 2, Spleen - Neutrophils	Low region specificity	Detected in many			Low region specificity	Detected in many								Secreted to blood	Enzyme	NA	NA	143000000	320000000		Cluster 83: Liver - Metabolism	Cluster 37: Neurons - Mixed function	Cluster 57: Stomach & Colon cancer - Digestion	Cluster 62: Hepatocytes - Metabolism	36				unprognostic (1.11e-2)		unprognostic (7.09e-2)	unprognostic (1.73e-1)	unprognostic (5.33e-1)	unprognostic (1.23e-1)			unprognostic (7.94e-2)					unprognostic (3.51e-4)	unprognostic (1.39e-1)	unprognostic (5.57e-3)	unprognostic (6.19e-2)	unprognostic (3.01e-1)	unprognostic (1.29e-2)			unprognostic (3.83e-3)	unprognostic (7.22e-2)		unprognostic (2.25e-1)	unprognostic (9.89e-2)	unprognostic (3.51e-2)	unprognostic (1.04e-1)	unprognostic (1.20e-1)		unprognostic (2.98e-1)
PGLYRP2	PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like	ENSG00000161031	Peptidoglycan recognition protein 2	Q96PD5	19	15468645-15498956	Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Immunity	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	45	liver: 250.7	Cell type enriched	Detected in some	8	Hepatocytes: 132.3	Cell type enhanced	Detected in some		leukocyte: 3.7	Cancer enriched	Detected in some	10	Liver Hepatocellular Carcinoma (TCGA): 79.2	Not detected	Not detected			Low immune cell specificity	Detected in many			Group enriched	Detected in many	7	"granulocytes: 3.4;monocytes: 5.1;T-cells: 2.3"	Group enriched	Detected in some	4	"Bone cancer: 4.9;breast cancer: 5.8"	Breast - Breast glandular cells, Breast - Breast glandular cells, Liver - Hepatocytes, Testis - Sertoli cells	Not detected	Not detected			Not detected	Not detected			CAB033468, HPA046311, HPA075237	Supported		Approved	Cell Junctions	Secreted to blood	Immunity	NA	NA		52000000000	Cluster 37: Monocytes & Neutrophils - Innate immune response	Cluster 31: Liver - Plasma proteins		Cluster 27: Breast cancer - Unknown function	Cluster 43: Hepatocytes - Metabolism		Cell Junctions		CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739		unprognostic (8.90e-2)	unprognostic (2.49e-2)											unprognostic (4.42e-3)	unprognostic (2.93e-4)																
PLG		ENSG00000122194	Plasminogen	P00747	6	160702194-160754097	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling	Hydrolase, Protease, Serine protease	Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	11	liver: 2571.0	Cell type enriched	Detected in some	8	Hepatocytes: 1618.7	Low cell type specificity	Detected in some			Cancer enriched	Detected in some	43	Liver Hepatocellular Carcinoma (TCGA): 341.7	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in single		liver cancer: 2.6	Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Respiratory ciliated cells	Not detected	Not detected			Low region specificity	Detected in all			CAB000668, CAB016678, HPA021602, HPA048823, HPA053770	Supported		Approved	Vesicles	Secreted to blood	Blood coagulation	NA	NA	1,4E+11	54000000000		Cluster 1: Liver & Kidney - Metabolism	Cluster 14: Neurons - Synaptic function	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	16	Vesicles		CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532, HPA053770: AB_2682256											unprognostic (4.99e-8)	unprognostic (5.03e-3)		unprognostic (2.54e-3)	unprognostic (2.09e-3)																
PLGLB2	PLGP1	ENSG00000125551	Plasminogen like B2	Q02325	2	87748087-87759476	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Tissue enriched	Detected in some	165	liver: 443.3	Cell type enriched	Detected in some	11	Hepatocytes: 66.2	Not detected	Not detected			Cancer enriched	Detected in single	34	Liver Hepatocellular Carcinoma (TCGA): 17.5	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in some												HPA053770			Approved	Vesicles	Secreted to blood	No annotated function	NA	NA				Cluster 31: Liver - Plasma proteins	Cluster 15: Non-specific - Transcription	Cluster 59: Leukemia - T-cell receptor	Cluster 43: Hepatocytes - Metabolism		Vesicles		HPA053770: AB_2682256			unprognostic (6.36e-2)			unprognostic (1.09e-1)								unprognostic (9.29e-3)	unprognostic (5.45e-4)											unprognostic (8.23e-2)					
PON1	ESA, PON	ENSG00000005421	Paraoxonase 1	P27169	7	95297676-95324532	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters		Hydrolase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	103	liver: 516.3	Cell type enriched	Detected in some	13	Hepatocytes: 428.5	Group enriched	Detected in some	11	"astrocyte: 15.4;bergmann glia: 13.8;oligodendrocyte precursor cell: 7.5"	Cancer enriched	Detected in single	70	Liver Hepatocellular Carcinoma (TCGA): 64.8	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		"liver cancer: 1.0;prostate cancer: 2.4"	Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA001610	Approved				Secreted to blood	Enzyme	NA	NA	96000000000	13000000000		Cluster 31: Liver - Plasma proteins	Cluster 10: Cerebellum - Nucleic acid binding	Cluster 59: Leukemia - T-cell receptor	Cluster 43: Hepatocytes - Metabolism	4			HPA001610: AB_1079656			unprognostic (2.19e-1)											unprognostic (3.48e-6)	unprognostic (7.76e-4)						unprognostic (1.23e-1)										
PON3		ENSG00000105852	Paraoxonase 3	Q15166	7	95359872-95396375	Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins		Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	20	liver: 598.0	Cell type enriched	Detected in many	9	Hepatocytes: 520.9	Group enriched	Detected in some	4	"astrocyte: 46.1;bergmann glia: 33.3;fibroblast: 51.7;oligodendrocyte precursor cell: 33.1;pericyte: 32.7"	Group enriched	Detected in many	8	"Liver Hepatocellular Carcinoma (TCGA): 105.8;Lung Adenocarcinoma (TCGA): 43.7"	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		liver cancer: 14.6	Heart muscle - Fibroblasts, Liver - Hepatocytes, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells, Pituitary gland - Gonadotropes, Skin - Sebaceous gland cells, Thyroid gland - Thyroid glandular cells	Low region specificity	Detected in all			Low region specificity	Detected in some			HPA014848, CAB025250	Enhanced				Secreted to blood	Enzyme	NA	NA	1760000000	450000000		Cluster 83: Liver - Metabolism	Cluster 41: Monoamines - Neurotransmitter signalling	Cluster 7: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	1			CAB025250: , HPA014848: AB_1855540	unprognostic (8.63e-2)	unprognostic (1.73e-1)	unprognostic (9.69e-2)	unprognostic (3.21e-2)	unprognostic (1.32e-1)	unprognostic (2.02e-2)			unprognostic (9.28e-2)			unprognostic (3.98e-3)		unprognostic (3.01e-4)	unprognostic (8.77e-4)	unprognostic (1.19e-1)	unprognostic (4.33e-1)	unprognostic (4.97e-2)	unprognostic (8.26e-3)	unprognostic (2.24e-2)	unprognostic (8.16e-2)	unprognostic (9.98e-2)	unprognostic (3.25e-3)		unprognostic (2.01e-1)	unprognostic (6.33e-3)		unprognostic (1.11e-1)	unprognostic (2.28e-1)	unprognostic (1.46e-1)	
PROC		ENSG00000115718	Protein C, inactivator of coagulation factors Va and VIIIa	P04070	2	127418427-127429242	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	40	liver: 584.1	Cell type enriched	Detected in some	4	Hepatocytes: 339.4	Cell type enhanced	Detected in some		"deep-layer near-projecting: 3.9;lower rhombic lip: 6.0"	Cancer enriched	Detected in many	8	Liver Hepatocellular Carcinoma (TCGA): 255.2	Low region specificity	Detected in many			Immune cell enriched	Detected in some	9	plasmacytoid DC: 59.8	Lineage enriched	Detected in many	9	dendritic cells: 59.8	Cancer enriched	Detected in many	6	liver cancer: 28.4	Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skin - Outer root sheath cells					Not detected	Not detected			HPA005550, CAB016721, CAB016792	Approved				Secreted to blood	Blood coagulation	NA	NA		3100000000	Cluster 8: Plasmacytoid DCs - Unknown function	Cluster 31: Liver - Plasma proteins	Cluster 26: Oligodendrocytes - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	2			CAB016721: , CAB016792: , HPA005550: AB_1079687	unprognostic (7.94e-3)		unprognostic (3.70e-1)	unprognostic (1.49e-3)	unprognostic (1.17e-1)	unprognostic (9.83e-2)			unprognostic (1.48e-2)		unprognostic (4.90e-3)	unprognostic (1.51e-2)	unprognostic (5.54e-3)	unprognostic (4.00e-3)	unprognostic (2.23e-4)	unprognostic (3.33e-1)	unprognostic (3.83e-2)	unprognostic (6.96e-2)				unprognostic (1.51e-2)	unprognostic (1.44e-1)	unprognostic (6.80e-2)	unprognostic (3.75e-2)	unprognostic (5.17e-2)		unprognostic (4.98e-3)	unprognostic (3.49e-1)	unprognostic (1.86e-2)	unprognostic (9.58e-3)
PROZ	PZ	ENSG00000126231	Protein Z, vitamin K dependent plasma glycoprotein	P22891	13	113158648-113172386	Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Serine protease homolog		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	liver: 106.6	Cell type enriched	Detected in some	7	Hepatocytes: 63.9	Not detected	Not detected			Cancer enriched	Detected in some	11	Liver Hepatocellular Carcinoma (TCGA): 14.0	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in some			Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected							HPA052006	Supported				Secreted to blood	Blood coagulation	NA	NA	1720000000	600000000		Cluster 1: Liver & Kidney - Metabolism	Cluster 5: Non-specific - Mixed function	Cluster 59: Leukemia - T-cell receptor	Cluster 62: Hepatocytes - Metabolism	1			HPA052006: AB_2681691			unprognostic (2.57e-1)							unprognostic (3.51e-2)				unprognostic (7.59e-4)	unprognostic (7.15e-3)																
PZP	CPAMD6	ENSG00000126838	PZP alpha-2-macroglobulin like	P20742	12	9148840-9208395	Cancer-related genes, Plasma proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	35	liver: 79.0	Cell type enhanced	Detected in some		"Ciliated cells: 12.1;Early spermatids: 28.3;Hepatocytes: 22.5;Late spermatids: 11.4;Oligodendrocyte precursor cells: 8.0"	Group enriched	Detected in many	5	"ependymal cell: 171.8;leukocyte: 66.1"	Cancer enhanced	Detected in some		"Liver Hepatocellular Carcinoma (TCGA): 1.1;Uterine Corpus Endometrial Carcinoma (TCGA): 1.0"	Low region specificity	Detected in all			Immune cell enhanced	Detected in some		"gdT-cell: 1.1;MAIT T-cell: 1.1"	Lineage enriched	Detected in single	11	T-cells: 1.1	Cancer enriched	Detected in single	9	cervical cancer: 1.9	Adipose subcutaneous - Endothelial cells, Lung - Respiratory ciliated cells, Skin - Endothelial cells, Testis - Early spermatids, Testis - Late spermatids									HPA041403, HPA041471	Supported				Secreted to blood	Enzyme inhibitor	NA	NA		26000000000	Cluster 1: T-cells - Unknown function	Cluster 31: Liver - Plasma proteins	Cluster 46: Brainstem - Mixed function	Cluster 7: Liver cancer - Metabolism	Cluster 42: Ciliated cells - Cilium assembly				HPA041403: AB_10804003, HPA041471: AB_10795636			unprognostic (3.02e-2)											unprognostic (1.21e-3)	unprognostic (3.62e-3)																unprognostic (5.32e-1)
RBP4		ENSG00000138207	Retinol binding protein 4	P02753	10	93591687-93601744	Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters	Sensory transduction, Transport, Vision		Cancer-related genes, Disease variant, Microphthalmia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	19	liver: 10726.7	Cell type enriched	Detected in many	13	Hepatocytes: 12476.9	Low cell type specificity	Detected in many			Cancer enriched	Detected in many	11	Liver Hepatocellular Carcinoma (TCGA): 5791.6	Region enriched	Detected in all	4	hypothalamus: 204.5	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in many	4	liver cancer: 195.7	Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Liver - Hepatocytes, Lung - Macrophages, Minor Salivary Gland - Adipocytes (Minor salivary gland), Pancreas - Beta cells, Skin - Adipocytes (Skin), Testis - Spermatogonia	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA001641, CAB004555	Supported				Secreted to blood	Transport	NA	NA	46100000000	1,2E+11		Cluster 83: Liver - Metabolism	Cluster 56: Hypothalamus - Neuropeptide signaling	Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	9			CAB004555: AB_670938, HPA001641: AB_1079795	unprognostic (6.15e-2)	unprognostic (1.40e-2)	unprognostic (2.97e-2)	unprognostic (2.68e-2)	unprognostic (3.83e-2)	unprognostic (1.66e-1)	unprognostic (1.73e-2)		unprognostic (2.84e-4)		unprognostic (1.39e-1)	unprognostic (5.27e-2)	unprognostic (1.38e-5)	unprognostic (2.57e-7)	unprognostic (6.90e-4)	unprognostic (1.05e-1)	unprognostic (1.76e-1)	unprognostic (1.81e-1)	unprognostic (3.01e-1)	unprognostic (1.42e-2)	unprognostic (3.76e-2)	unprognostic (3.57e-1)	unprognostic (1.66e-1)	unprognostic (5.26e-1)	unprognostic (3.03e-2)	unprognostic (8.48e-2)	unprognostic (2.18e-1)	unprognostic (1.19e-3)	unprognostic (2.50e-1)	unprognostic (3.99e-2)	unprognostic (1.59e-2)
RNASE4	RAB1	ENSG00000258818	Ribonuclease A family member 4	P34096	14	20684560-20701216	Plasma proteins, Predicted secreted proteins		Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	4	liver: 463.8	Cell type enhanced	Detected in many		"Enteroendocrine cells: 56.1;Gastric mucus-secreting cells: 48.9;Hepatocytes: 47.7;Intestinal goblet cells: 97.9;Proximal enterocytes: 38.9"	Cell type enhanced	Detected in some		"fibroblast: 14.6;pericyte: 19.5;vascular associated smooth muscle cell: 26.1"	Cancer enhanced	Detected in all		Liver Hepatocellular Carcinoma (TCGA): 92.0	Low region specificity	Detected in all			Immune cell enhanced	Detected in many		classical monocyte: 24.1	Low lineage specificity	Detected in many			Low cancer specificity	Detected in many			Adrenal gland - Fibroblasts, Heart muscle - Fibroblasts, Liver - Hepatocytes, Minor Salivary Gland - Minor salivary glandular cells, Spleen - Fibroblast_2, Thyroid gland - Fibroblasts	Low region specificity	Detected in all			Low region specificity	Detected in all								Secreted to blood	Enzyme	NA	NA		59000000	Cluster 2: Dendritic cells - Unknown function	Cluster 83: Liver - Metabolism	Cluster 39: Astrocytes - Mixed function	Cluster 2: Mucus-secreting cells - Unknown function	Cluster 16: Intestinal goblet cells - Mucin production	1				unprognostic (1.48e-1)	unprognostic (8.01e-2)	unprognostic (5.32e-2)	unprognostic (4.08e-2)	unprognostic (1.73e-2)	unprognostic (5.35e-1)	unprognostic (6.35e-3)		unprognostic (7.00e-2)	unprognostic (1.15e-1)	unprognostic (2.36e-5)	unprognostic (7.63e-4)	unprognostic (3.32e-3)	unprognostic (1.53e-5)	unprognostic (1.96e-3)	unprognostic (9.39e-2)	unprognostic (1.79e-1)	unprognostic (4.86e-2)	unprognostic (2.53e-2)	unprognostic (7.11e-2)	unprognostic (2.87e-1)	unprognostic (6.95e-2)	unprognostic (3.57e-3)	unprognostic (1.41e-1)	unprognostic (1.34e-1)	unprognostic (9.45e-5)	unprognostic (1.60e-1)	unprognostic (2.56e-3)	unprognostic (2.50e-1)	unprognostic (6.66e-2)	unprognostic (1.09e-1)
SAA1	PIG4, SAA, TP53I4	ENSG00000173432	Serum amyloid A1	P0DJI8	11	18266260-18269977	Disease related genes, Predicted secreted proteins	Acute phase	Heparin-binding	Amyloidosis	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	20	liver: 46934.0	Cell type enriched	Detected in many	9	Hepatocytes: 88360.6	Not detected	Not detected			Cancer enriched	Detected in all	4	Liver Hepatocellular Carcinoma (TCGA): 1671.3	Group enriched	Detected in many	5	"choroid plexus: 3.7;pons: 8.3;thalamus: 14.1"	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		head and neck cancer: 445.5	Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Minor Salivary Gland - Minor salivary glandular cells														Secreted to blood	Acute phase	NA	NA	300000000	6300000000		Cluster 83: Liver - Metabolism	Cluster 12: Non-specific - Vasculature	Cluster 53: Squamous epithelial cells - Keratinization	Cluster 62: Hepatocytes - Metabolism	1				unprognostic (3.88e-2)	unprognostic (1.93e-3)	unprognostic (3.15e-2)	unprognostic (8.16e-2)	unprognostic (2.06e-1)	unprognostic (2.32e-1)	unprognostic (1.90e-3)	unprognostic (5.04e-4)	unprognostic (2.59e-2)	unprognostic (3.80e-2)	unprognostic (1.81e-10)	unprognostic (6.77e-5)	unprognostic (3.94e-2)	unprognostic (2.50e-2)	unprognostic (1.19e-4)	unprognostic (7.28e-2)	unprognostic (6.10e-3)	unprognostic (2.32e-1)	unprognostic (4.30e-3)	unprognostic (1.40e-3)	unprognostic (1.32e-1)	unprognostic (1.43e-1)	unprognostic (6.66e-2)	unprognostic (7.28e-2)	unprognostic (5.37e-2)	unprognostic (1.87e-1)	unprognostic (3.06e-1)	unprognostic (1.59e-2)	unprognostic (7.87e-2)	unprognostic (2.26e-2)	unprognostic (3.22e-1)
SAA2		ENSG00000134339	Serum amyloid A2	P0DJI9	11	18239223-18248668	Disease related genes, Predicted secreted proteins	Acute phase		Amyloidosis	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	20	liver: 35358.8	Cell type enriched	Detected in many	6	Hepatocytes: 43517.4	Low cell type specificity	Detected in some			Cancer enriched	Detected in many	20	Liver Hepatocellular Carcinoma (TCGA): 1208.1	Group enriched	Detected in all	4	"pons: 17.8;thalamus: 22.2"	Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		head and neck cancer: 394.0	Adipose visceral - Adipocytes (Visceral), Minor Salivary Gland - Minor salivary glandular cells														Secreted to blood	Acute phase	NA	NA	50000000	5200000000		Cluster 83: Liver - Metabolism	Cluster 12: Non-specific - Vasculature	Cluster 53: Squamous epithelial cells - Keratinization	Cluster 62: Hepatocytes - Metabolism	4				unprognostic (2.89e-4)	unprognostic (5.27e-3)	unprognostic (1.28e-3)	unprognostic (3.44e-2)	unprognostic (2.48e-1)	unprognostic (2.31e-1)	unprognostic (5.20e-4)	unprognostic (7.71e-3)	unprognostic (4.31e-2)	unprognostic (3.27e-1)	unprognostic (2.47e-10)	unprognostic (7.19e-4)	unprognostic (7.32e-2)	unprognostic (6.41e-2)	unprognostic (3.09e-4)	unprognostic (1.05e-1)	unprognostic (3.66e-2)	unprognostic (8.45e-2)	unprognostic (4.19e-2)	unprognostic (7.89e-3)	unprognostic (2.23e-1)	unprognostic (2.27e-2)	unprognostic (2.64e-2)	unprognostic (1.04e-1)	unprognostic (2.98e-1)	unprognostic (2.14e-1)	unprognostic (1.22e-1)	unprognostic (5.40e-2)		unprognostic (1.38e-1)	unprognostic (3.15e-1)
SAA4	C-SAA, CSAA	ENSG00000148965	Serum amyloid A4, constitutive	P35542	11	18231355-18236802	Plasma proteins, Predicted secreted proteins	Acute phase			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	125	liver: 1879.5	Cell type enriched	Detected in some	34	Hepatocytes: 1673.3	Low cell type specificity	Detected in single			Cancer enriched	Detected in many	108	Liver Hepatocellular Carcinoma (TCGA): 430.7	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		"Bile duct cancer: 4.4;head and neck cancer: 6.3;liver cancer: 5.5"	Adipose visceral - Adipocytes (Visceral), Liver - Hepatocytes, Minor Salivary Gland - Minor salivary glandular cells, Testis - Early spermatids, Testis - Late spermatids	Not detected	Not detected							CAB026061, HPA060139	Supported				Secreted to blood	Acute phase	NA	NA	65000000000	19000000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	2			CAB026061: , HPA060139: AB_2684210	unprognostic (3.23e-3)	unprognostic (6.27e-3)	unprognostic (1.04e-1)	unprognostic (1.87e-1)							unprognostic (3.88e-8)	unprognostic (1.23e-3)	unprognostic (9.56e-2)	unprognostic (5.73e-3)	unprognostic (2.90e-4)	unprognostic (1.00e-1)	unprognostic (2.63e-2)	unprognostic (1.76e-1)	unprognostic (2.00e-2)		unprognostic (3.34e-1)	unprognostic (2.29e-1)						unprognostic (1.38e-1)			unprognostic (4.95e-2)
SERPINA1	A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1	ENSG00000197249	Serpin family A member 1	P01009	14	94376747-94390693	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase, Blood coagulation, Hemostasis	Protease inhibitor, Serine protease inhibitor	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	45	liver: 33156.1	Cell type enriched	Detected in many	7	Hepatocytes: 38353.1	Group enriched	Detected in some	8	"central nervous system macrophage: 14.8;leukocyte: 17.5"	Cancer enriched	Detected in all	10	Liver Hepatocellular Carcinoma (TCGA): 13009.7	Low region specificity	Detected in all			Group enriched	Detected in all	5	"classical monocyte: 2484.3;intermediate monocyte: 3414.0;neutrophil: 2835.2;non-classical monocyte: 4540.7"	Group enriched	Detected in all	5	"granulocytes: 2835.2;monocytes: 4540.7"	Cancer enhanced	Detected in many		"Gastric cancer: 303.1;liver cancer: 783.6;lymphoma: 293.1"	Adipose visceral - Neutrophils, Liver - Hepatocytes, Skeletal muscle - Neutrophils, Spleen - Neutrophils	Not detected	Not detected							HPA000927, HPA001292, CAB013211, CAB016648, CAB073396	Enhanced		Enhanced	Vesicles	Secreted to blood	Blood coagulation	NA	NA	1,92E+12	1,8E+11	Cluster 37: Monocytes & Neutrophils - Innate immune response	Cluster 83: Liver - Metabolism	Cluster 12: Non-specific - Vasculature	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	11	Vesicles		CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762	unprognostic (7.43e-2)	unprognostic (8.20e-5)	unprognostic (2.25e-1)	unprognostic (7.97e-2)	unprognostic (1.10e-2)	unprognostic (1.44e-1)	unprognostic (3.87e-2)	unprognostic (1.01e-1)	unprognostic (2.22e-2)	unprognostic (3.33e-2)	unprognostic (1.42e-3)	unprognostic (1.66e-2)	unprognostic (1.34e-2)	unprognostic (4.60e-2)	unprognostic (7.63e-3)	unprognostic (3.21e-1)	unprognostic (2.30e-1)	unprognostic (3.56e-3)	unprognostic (4.07e-2)	unprognostic (1.31e-1)	unprognostic (2.43e-1)	unprognostic (4.10e-2)	unprognostic (2.75e-2)	unprognostic (3.34e-1)	unprognostic (2.66e-1)	unprognostic (7.25e-4)	unprognostic (4.11e-2)	unprognostic (1.14e-1)	unprognostic (5.95e-3)	unprognostic (2.83e-2)	unprognostic (9.14e-2)
SERPINA10	PZI, ZPI	ENSG00000140093	Serpin family A member 10	Q9UK55	14	94280460-94293268	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Heparin-binding, Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	113	liver: 338.3	Cell type enriched	Detected in some	17	Hepatocytes: 217.4	Cell type enhanced	Detected in single		hippocampal dentate gyrus: 1.1	Cancer enriched	Detected in some	40	Liver Hepatocellular Carcinoma (TCGA): 75.5	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in many			Breast - Breast glandular cells, Liver - Hepatocytes, Pancreas - Alpha cells, Stomach - Gastric enteroendocrine cells	Not detected	Not detected							HPA048739			Approved	Nucleoplasm,Cytosol	Secreted to blood	Blood coagulation	NA	NA	3960000000	3200000000		Cluster 31: Liver - Plasma proteins	Cluster 9: Non-specific - Receptor signaling	Cluster 10: Ciliated cells - Ion channel activity	Cluster 62: Hepatocytes - Metabolism	6	Nucleoplasm	Cytosol	HPA048739: AB_2797237			unprognostic (4.39e-1)		unprognostic (1.14e-1)	unprognostic (1.67e-1)								unprognostic (6.62e-4)	unprognostic (2.04e-5)		unprognostic (3.68e-2)					unprognostic (8.86e-4)			unprognostic (1.51e-3)	unprognostic (3.35e-1)		unprognostic (1.74e-3)			
SERPINA11		ENSG00000186910	Serpin family A member 11	Q86U17	14	94442464-94452800	Plasma proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Tissue enriched	Detected in some	93	liver: 475.6	Cell type enriched	Detected in some	9	Hepatocytes: 259.5	Not detected	Not detected			Cancer enriched	Detected in some	7	Liver Hepatocellular Carcinoma (TCGA): 102.7	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	11	"liver cancer: 4.9;lymphoma: 2.3"	Breast - Breast glandular cells, Liver - Hepatocytes, Minor Salivary Gland - Minor salivary glandular cells	Not detected	Not detected			Not detected	Not detected								Secreted to blood	Enzyme inhibitor	NA	NA		160000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism						unprognostic (4.38e-2)	unprognostic (7.59e-2)											unprognostic (1.70e-2)	unprognostic (1.71e-5)									unprognostic (2.31e-1)							unprognostic (2.08e-1)
SERPINA4	KAL, KLST, KST, PI4	ENSG00000100665	Serpin family A member 4	P29622	14	94561442-94569913	Plasma proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 533.2	Group enriched	Detected in some	7	"Cholangiocytes: 225.1;Exocrine glandular cells: 103.6;Hepatocytes: 397.4"	Not detected	Not detected			Cancer enriched	Detected in many	4	Liver Hepatocellular Carcinoma (TCGA): 142.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	"Bile duct cancer: 2.3;colorectal cancer: 1.5;Gastric cancer: 2.1;liver cancer: 5.6"	Liver - Hepatocytes, Stomach - Parietal cells					Not detected	Not detected			HPA003607, HPA068939	Approved		Uncertain	Vesicles	Secreted to blood	Enzyme inhibitor	NA	NA	14500000000	11000000000		Cluster 83: Liver - Metabolism		Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism	2	Vesicles		HPA003607: AB_1079914, HPA068939: 			unprognostic (1.18e-1)	unprognostic (3.52e-1)		unprognostic (1.47e-1)				unprognostic (2.88e-2)	unprognostic (5.48e-4)	unprognostic (6.58e-2)	unprognostic (4.70e-2)	unprognostic (9.73e-4)	unprognostic (4.38e-3)	unprognostic (7.24e-3)						unprognostic (2.50e-3)	unprognostic (1.10e-1)			unprognostic (3.05e-1)		unprognostic (1.29e-1)	unprognostic (1.84e-1)		unprognostic (2.64e-1)
SERPINA6	CBG	ENSG00000170099	Serpin family A member 6	P08185	14	94304248-94323389	Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins	Transport		Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	18	liver: 752.4	Group enriched	Detected in some	4	"Cholangiocytes: 223.2;Hepatocytes: 335.3"	Not detected	Not detected			Cancer enriched	Detected in many	10	Liver Hepatocellular Carcinoma (TCGA): 316.7	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		"breast cancer: 10.6;liver cancer: 21.0"	Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Respiratory ciliated cells	Not detected	Not detected			Low region specificity	Detected in single			HPA017864	Approved				Secreted to blood	Transport	NA	NA	60800000000	22000000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	2			HPA017864: AB_1856721		unprognostic (6.44e-2)	unprognostic (1.78e-1)		unprognostic (5.96e-2)	unprognostic (1.26e-1)					unprognostic (1.07e-3)	unprognostic (1.94e-1)	unprognostic (2.37e-1)	unprognostic (1.10e-2)	unprognostic (9.64e-4)							unprognostic (4.00e-3)	unprognostic (2.98e-1)		unprognostic (6.59e-2)	unprognostic (3.60e-2)		unprognostic (2.10e-2)			unprognostic (3.36e-1)
SERPINA7	TBG	ENSG00000123561	Serpin family A member 7	P05543	X	106032435-106038727	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	611	liver: 273.6	Cell type enriched	Detected in some	15	Hepatocytes: 163.2	Not detected	Not detected			Cancer enriched	Detected in single	203	Liver Hepatocellular Carcinoma (TCGA): 92.6	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enriched	Detected in single	18	liver cancer: 5.5	Liver - Hepatocytes	Not detected	Not detected			Not detected	Not detected			HPA002803	Approved				Secreted to blood	Transport	NA	NA	39800000000	18000000000		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism				HPA002803: AB_1079915														unprognostic (5.22e-3)	unprognostic (1.03e-3)																
SERPINC1	AT3, ATIII, MGC22579	ENSG00000117601	Serpin family C member 1	P01008	1	173903800-173917327	Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Heparin-binding, Protease inhibitor, Serine protease inhibitor	Disease variant, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	1350	liver: 4902.3	Cell type enriched	Detected in some	36	Hepatocytes: 2537.3	Not detected	Not detected			Cancer enriched	Detected in some	605	Liver Hepatocellular Carcinoma (TCGA): 1905.0	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	"Gastric cancer: 1.6;liver cancer: 5.7"	Kidney - Proximal tubular cells, Liver - Hepatocytes	Not detected	Not detected			Low region specificity	Detected in all			HPA001816, CAB016790, HPA024007	Supported				Secreted to blood	Blood coagulation	NA	NA		1,1E+11		Cluster 31: Liver - Plasma proteins		Cluster 18: Liver cancer - Metabolism	Cluster 43: Hepatocytes - Metabolism				CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732			unprognostic (7.44e-2)								unprognostic (3.51e-2)			unprognostic (1.63e-5)	unprognostic (1.33e-4)																
SERPIND1	D22S673, HC-II, HC2, HCF2, HLS2	ENSG00000099937	Serpin family D member 1	P05546	22	20774113-20787720	Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Chemotaxis, Hemostasis	Heparin-binding, Protease inhibitor, Serine protease inhibitor	Disease variant, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 1214.6	Cell type enriched	Detected in some	13	Hepatocytes: 238.0	Cell type enhanced	Detected in all		choroid plexus epithelial cell: 13.3	Cancer enriched	Detected in many	46	Liver Hepatocellular Carcinoma (TCGA): 416.5	Region enriched	Detected in all	21	choroid plexus: 191.0	Not detected in immune cells	Not detected			Not detected	Not detected			Group enriched	Detected in many	15	"liver cancer: 30.6;ovarian cancer: 66.9"	Liver - Hepatocytes, Thyroid gland - Fibroblasts	Low region specificity	Detected in all			Low region specificity	Detected in some			CAB008639, HPA055767	Supported		Approved	Vesicles	Secreted to blood	Blood coagulation	NA	NA		40000000000	Cluster 30: Non-specific - DNA binding	Cluster 31: Liver - Plasma proteins	Cluster 36: Choroid plexus - Mixed function	Cluster 66: Non-specific - Mitochondria	Cluster 62: Hepatocytes - Metabolism	4	Vesicles		CAB008639: AB_1618010, HPA055767: AB_2682912			unprognostic (1.72e-1)			unprognostic (7.09e-3)					unprognostic (1.98e-3)			unprognostic (6.37e-3)	unprognostic (1.07e-1)	unprognostic (1.04e-2)	unprognostic (6.39e-2)	unprognostic (2.39e-4)	unprognostic (2.85e-1)			unprognostic (2.59e-2)			unprognostic (1.62e-1)	unprognostic (1.97e-1)		unprognostic (8.75e-2)	unprognostic (5.35e-2)		
SERPINF2	A2AP, AAP, ALPHA-2-PI, alpha2AP, API, PLI	ENSG00000167711	Serpin family F member 2	P08697	17	1742836-1755265	Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins	Acute phase	Protease inhibitor, Serine protease inhibitor	Disease variant	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	16	liver: 1539.8	Cell type enriched	Detected in many	4	Hepatocytes: 814.9	Cell type enhanced	Detected in many		choroid plexus epithelial cell: 15.3	Cancer enriched	Detected in many	4	Liver Hepatocellular Carcinoma (TCGA): 406.8	Region enriched	Detected in all	7	choroid plexus: 21.0	Immune cell enriched	Detected in some	4	plasmacytoid DC: 44.8	Lineage enriched	Detected in many	23	dendritic cells: 44.8	Group enriched	Detected in many	14	"Gastric cancer: 46.8;liver cancer: 36.6"	Kidney - Proximal tubular cells, Liver - Hepatocytes, Skin - Macrophages	Not detected	Not detected			Low region specificity	Detected in many			HPA001885, HPA005943, CAB024863	Approved		Approved	Golgi apparatus	Secreted to blood	Acute phase	NA	NA	11900	47000000000	Cluster 8: Plasmacytoid DCs - Unknown function	Cluster 31: Liver - Plasma proteins	Cluster 36: Choroid plexus - Mixed function	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	4	Golgi apparatus		CAB024863: , HPA001885: AB_1079922, HPA005943: 	unprognostic (5.96e-4)	unprognostic (4.40e-2)	unprognostic (1.65e-1)	unprognostic (1.07e-2)	unprognostic (3.34e-1)	unprognostic (3.86e-1)	unprognostic (2.28e-1)		unprognostic (2.88e-3)	unprognostic (1.78e-1)	unprognostic (5.28e-3)	unprognostic (2.45e-3)	unprognostic (7.60e-3)	unprognostic (1.22e-3)	unprognostic (1.18e-3)	unprognostic (1.06e-1)	unprognostic (2.91e-1)	unprognostic (3.73e-2)	unprognostic (2.45e-1)			unprognostic (2.14e-1)	unprognostic (3.43e-4)	unprognostic (9.95e-2)	unprognostic (1.54e-1)	unprognostic (3.01e-1)	unprognostic (2.46e-1)	unprognostic (3.61e-1)	unprognostic (2.19e-1)		unprognostic (8.67e-3)
SHBG	ABP, MGC126834, MGC138391, TEBG	ENSG00000129214	Sex hormone binding globulin	P04278	17	7613946-7633382	Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins			Cancer-related genes, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 61.5	Cell type enhanced	Detected in some		"Early spermatids: 51.9;Late spermatids: 124.0;Proximal enterocytes: 28.6"	Low cell type specificity	Detected in many			Cancer enriched	Detected in some	19	Liver Hepatocellular Carcinoma (TCGA): 25.2	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Low cancer specificity	Detected in some			Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Testis - Late spermatids	Not detected	Not detected												Secreted to blood	Transport	NA	NA		6100000000		Cluster 83: Liver - Metabolism	Cluster 39: Astrocytes - Mixed function	Cluster 72: Neuronal - Signal transduction	Cluster 36: Late spermatids - Unknown function							unprognostic (2.33e-1)				unprognostic (4.50e-2)							unprognostic (1.80e-1)	unprognostic (1.38e-2)														unprognostic (2.77e-1)		
SPP2	SPP24	ENSG00000072080	Secreted phosphoprotein 2	Q13103	2	234050679-234077134	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	4403	liver: 502.9	Cell type enriched	Detected in some	28	Hepatocytes: 246.6	Not detected	Not detected			Cancer enriched	Detected in some	56	Liver Hepatocellular Carcinoma (TCGA): 93.7	Not detected	Not detected			Not detected in immune cells	Not detected			Not detected	Not detected			Not detected	Not detected			Liver - Hepatocytes	Low region specificity	Detected in some			Low region specificity	Detected in all								Secreted to blood	No annotated function	NA	NA		290000000		Cluster 31: Liver - Plasma proteins		Cluster 5: Rhabdoid - Unknown function	Cluster 43: Hepatocytes - Metabolism																		unprognostic (9.13e-7)	unprognostic (9.08e-3)	unprognostic (2.51e-2)	unprognostic (4.11e-2)				unprognostic (4.40e-1)		unprognostic (3.91e-2)								
THPO	MGDF, MPLLG, TPO	ENSG00000090534	Thrombopoietin	P40225	3	184371935-184381968	Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins		Cytokine, Hormone	Cancer-related genes, Disease variant	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	liver: 34.5	Cell type enhanced	Detected in some		"Early spermatids: 2.0;Excitatory neurons: 2.1;Hepatocytes: 11.9;Late spermatids: 2.9;Proximal tubular cells: 9.1"	Cell type enhanced	Detected in many		upper-layer intratelencephalic: 5.6	Cancer enriched	Detected in many	4	Liver Hepatocellular Carcinoma (TCGA): 10.9	Low region specificity	Detected in many			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in some		"liver cancer: 4.1;lymphoma: 3.1"	Kidney - Proximal tubular cells, Testis - Early spermatids, Testis - Late spermatids	Low region specificity	Detected in many			Low region specificity	Detected in all								Secreted to blood	Cytokine	NA	NA	1070000			Cluster 69: Liver - Oxidoreductase activity	Cluster 34: Non-specific - Mixed function	Cluster 10: Ciliated cells - Ion channel activity	Cluster 56: Proximal tubular cells - Amino acid metabolism						unprognostic (3.43e-2)	unprognostic (4.08e-2)								unprognostic (1.19e-1)	unprognostic (6.85e-2)	unprognostic (2.08e-2)	unprognostic (2.49e-2)	unprognostic (2.62e-3)	unprognostic (2.61e-1)	unprognostic (1.41e-1)											unprognostic (2.43e-3)	unprognostic (4.15e-1)		unprognostic (5.92e-2)
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367284-28373091	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins, Transporters	Cell adhesion	Heparin-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	61	liver: 5852.0	Cell type enriched	Detected in many	4	Hepatocytes: 4354.3	Low cell type specificity	Detected in many			Cancer enriched	Detected in many	70	Liver Hepatocellular Carcinoma (TCGA): 4074.6	Low region specificity	Detected in all			Not detected in immune cells	Not detected			Not detected	Not detected			Cancer enhanced	Detected in many		liver cancer: 132.3	Adipose visceral - Mesothelial cells, Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes	Low region specificity	Detected in all			Low region specificity	Detected in many			CAB016695, CAB016765, HPA060933, HPA068011	Supported		Supported	Endoplasmic reticulum,Vesicles	Secreted to blood	Cell adhesion	NA	NA	6,06E+11	37000000000		Cluster 31: Liver - Plasma proteins	Cluster 15: Non-specific - Transcription	Cluster 18: Liver cancer - Metabolism	Cluster 62: Hepatocytes - Metabolism	19	Endoplasmic reticulum, Vesicles		CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: 	unprognostic (1.04e-1)	unprognostic (3.62e-2)	unprognostic (2.25e-1)	unprognostic (3.67e-2)		unprognostic (1.31e-1)					unprognostic (5.00e-5)	unprognostic (8.05e-2)	unprognostic (6.19e-5)	unprognostic (3.24e-4)	unprognostic (3.32e-5)	unprognostic (2.18e-1)	unprognostic (1.45e-1)	unprognostic (5.38e-5)				unprognostic (9.05e-3)		unprognostic (5.73e-3)		unprognostic (7.37e-2)	unprognostic (3.39e-1)	unprognostic (1.69e-3)	unprognostic (2.47e-1)		